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INTRODUCTION 
Together with luteinizing hormone (LH) and chorionic gonadotropin (CG), 
follicle-stimulating hormone (FSH) belongs to the gonadotropin hormones 
family. Multiple past and recent physiological and biochemical studies 
elucidated the essential roles of gonadotropins in reproductive processes in 
mammals (Pierce and Parsons 1981, Moyle and Campbell 1996). In human, 
FSH and LH produced by pituitary are involved in hypothalamic-pituitary-
gonadal axis and are required for ovulation and spermatogenesis in females and 
males, respectively (reviewed in Edson et al. 2009, Weinbauer et al. 2010). 
Primate-specific CG secreted solely in placenta contributes profoundly to 
embryo implantation and maintenance of pregnancy (Moyle and Campbell 
1996).  
 Gonadotropins are heterodimeric proteins composed of two subunits. The α-
subunit is common in all gonadotropins, whereas β-subunit dictates receptor-
binding specificity and unique function of the hormone. The genes encoding for 
FSH, LH and CG β-subunits have been suggested to have common evolutionary 
ancestry and belong to gonadotropin hormone β-subunit gene family. In human, 
follicle-stimulating hormone β-subunit is encoded by the FSHB gene (11p13), 
whereas the genes encoding for LH and hCG β-subunits are located in the 
cluster of duplicated genes (LHB/CGB, 19q13) consisting of one LHB gene and 
six CGB genes. Phylogenetic analyses have elucidated the high sequence con-
servation of the entire FSHB gene along with its upstream and downstream 
regions throughout the vertebrate lineage (Kumar et al. 2006). The high se-
quence conservation mirrors strong selective pressure acting towards the entire 
FSHB gene and its flanking sequences.  
  There has been growing interest towards the mapping of common genetic 
variants that contribute to human phenotypic diversity and prevalence of a 
disease. Despite the intense research on genetics of fertility and essential 
function of the FSH reproduction, there is limited number of studies describing 
the FSHB gene common sequence variation pattern (Liao et al. 1999, Lam-
minen et al. 2005). Possible contribution of the FSHB common genetic variants 
to the heterogeneity of the fertility phenotype remains largely unexplained and 
possibly underestimated. As yet, genome-wide association studies interrogating 
the genetic basis for variation in common human traits have not reported any 
FSHB common variant to be significantly associated with variation of human 
fertility phenotype (Hindorff et al. 2011). However, due to the stringent statis-
tical corrections obligatory for large-scale studies, true genetic associations 
might have been overlooked. Comparison of the intra- and interspecies se-
quence diversity of biologically relevant genes, such as the FSHB gene, could 
allow functionally important genetic variants to be defined. 
 In this thesis, the literature review gives an overview of the evolutionary 
context, molecular structure, and function of the gonadotropin hormones. The 
second major part of the overview focuses on the genetics of gonadotropin 
subunits coding genes, the detailed genetic variation pattern of the human 
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follicle-stimulating hormone β-subunit coding gene (FSHB), and the regulation 
of the FSHB gene expression. 
 The experimental part of the current thesis investigates the worldwide fine-
scale genetic variation pattern of the FSHB gene and possible association of the 
gene variants with female reproductive success. Additionally, this research in-
cludes in silico screening of the FSHB gene conserved flanking sequences 
resulted in the isolation of the putative gene expression-associated promoter 
polymorphism (–211 G/T, rs10835638) residing in transcription factor-binding 
site, Progesterone Response Element (PRE). This genetic variant was pre-
viously shown to represent functional regulatory locus associated with gene 
expression regulation (Webster et al. 1995, Hoogendoorn et al. 2003). In the 
framework of the current thesis, genetic association study is conducted to 
evaluate the association of the detected putative regulatory polymorphic 
position within the FSHB promoter with male reproductive parameters, in the 
Baltic cohort of young men (Estonians, Latvians and Lithuanians) and in the 
Estonian cohort of patients diagnosed with infertility. 
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1. REVIEW OF LITERATURE 
1.1. Gonadotropin hormones 
1.1.1. Evolutionary context of glycoprotein gonadotropins 
The family of glycoprotein hormones includes thyroid stimulating hormone 
(TSH) and gonadotropin hormones: follicle-stimulating hormone (FSH), luteini-
zing hormone (LH) and chorionic gonadotropin (CG). Glycoprotein gonado-
tropins have the essential roles in reproductive processes and have been intensi-
vely studied in various animal species (Table 1). Gonadotropins are absent from 
the closest relatives to vertebrates, invertebrates marine chordate Ciona intesti-
nalis and lancelets (e.g. Branchiostoma sp.), which represent the evolutionary 
lineage between vertebrates and invertebrates (Campbell et al. 2004, Holland et 
al. 2008, Kano 2010). However, in lancelets, a homolog for the thyrostimulin, a 
recently discovered glycoprotein synthesized by anterior pituitary also in 
vertebrates, has been identified (Nakabayashi et al. 2002, Campbell et al. 2004, 
Tando and Kubokawa 2009). The presence of a functional heterodimeric glyco-
protein gonadotropin has been elucidated from the most primitive vertebrates, 
brown hagfish (Paramyxine atami) and sea lamprey (Lampetra fluviatilis) 
(Uchida et al. 2010, Sower et al. 2006). In all representatives of more complex 
vertebrates (Gnathostomes) including fishes, two gonadotropin hormones and 
TSH have been identified (Table 1; Schulz et al. 2001a, 2001b). 
The accelerated evolution in mammals has led to further diversification of 
the gonadotropin hormones family giving rise to an additional hormone with 
novel function. The homolog for LH–CG–is produced in the placenta of 
primates and a few equines such as horse, donkey and zebra (Moyle and Camp-
bell 1996). In equines, eLH and eCG have identical amino acid composition and 
differ in post-translational modification pattern. In primates, LH and CG 
represent separately encoded proteins with distinct patterns of expression and 
function. 
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Table 1. Gonadotropin hormones FSH, LH, CG, or their analogues identified in 
selected representatives of Chordates (phylum Chordata). 
  FSH LH CG References 
Cephalochordates amphioxus, 
lancelets 
– – – Holland et al. 2008 
Hallböök et al. 2008 
Urochordates ascidian, 
sea squirt 
– – – reviewed in Campbell et 
al. 2004 
Craniates  
Jawless vertebrates 
(agnathans) 
sea lamprey, 
brown hagfish 
GTH-like 
hormone 
– Uchida et al. 2010, 
Sower et al. 2006 
Jawed vertebrates 
(gnathostomes) 
  
 teleost 
fish 
chum salmon, 
sturgeon, Australian 
lungfish, zebrafish 
GTH I GTH II – Suzuki et al. 1988, 
Swanson et al. 1991, 
Laan et al. 2002, Quérat 
et al. 2000, 2004, Lin and 
Ge 2009 
tetrapods  reptiles snakes, lizards FSH-like 
gonadotropin 
 Licht 1972a, Licht et al. 
1979 
 turtles, 
American alligator 
+ +* – Licht and Papkoff 1974a,  
Licht 1972b, Licht et al. 
1976 
amphibians frogs, 
salamanders 
+ + – Licht and Papkoff 1974b, 
Licht et al. 1975, Farmer 
et al. 1977 
birds  chicken, 
turkey 
+ + – Stockell-Hartree and 
Cunningham 1969, 
Farmer et al. 1975 
mammals rodents mouse 
rat 
+ + – Harris and Jacobsohn 
1952, Inoue and 
Kirosumi 1984 
 
equines horse, donkey, 
zebra 
+ eLH/eCG Chopineau et al. 1999, 
Murphy and Martinuk 
1991 
Sherman et al. 1992 
primates New World monkeys 
(e.g. marmoset, 
squirrel monkey)  
+ – + Simula et al. 1995, 
Gromoll et al. 2003, 
Müller et al. 2004, 
Vasauskas et al. 2011 
 Old World monkeys 
(e.g. macaques), great 
apes (chimpanzee, 
gorilla, orangutan), 
human 
+ + + Maston and Ruvolo 
2002, Hallast and Laan 
2009 
* Green turtle (Chelonia mydas) LH shows an ability to interact with FSH receptor sites 
(cross-reactivity) and to stimulate physiological functions normally attributed to FSH. 
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1.1.2 Molecular basis of gonadotropins 
1.1.2.1 Molecular structure of gonadotropins 
Gonadotropins are members of the superfamily of cystine knot growth factors 
that includes also nerve growth factors, activins, transforming growth factor-β, 
and platelet-derived growth factor-β. Gonadotropins differ from other cystine 
knot growth factors in that both homodimers forming intact heterodimeric hor-
mone are glycosylated (Sun and Davies, 1995).  
Gonadotropin hormones are relatively large heterodimeric proteins each 
composed of α- and β-subunits that are joined by non-covalent hydrophobic and 
ionic interactions. α-subunit has identical amino acid sequence for each of the 
gonadotropins, whereas β-subunit confers a unique immunological and biologi-
cal conformation and mediates the binding to the hormone’s receptor (Pierce 
and Parsons, 1981).  
Glycoprotein hormones exert their actions via the rhodopsin-like receptors 
belonging to the superfamily of G protein-coupled receptors (GPCRs) charac-
terized by seven helices flanked by extracellular and intracellular domains. 
GPCRs family also include the β-adrenergic receptors, the rhodopsin receptor, 
the catecholamine receptors (Sprengel et al. 1990, Palczewski et al. 2000).  
 
1.1.2.2 Molecular structure of follicle-stimulating hormone 
Deglycosylated FSH has a molecular weight of 35 kDa and is comprised of 92 
amino acid α-subunit and 111 amino acid β-subunit (Ryan et al. 1971, Fox et al. 
2001). The α- and β-subunit are non-covalently associated forming an elongated 
slightly curved dimer (Figure 1). During dimer formation, C-terminal amino 
acids of the β-subunit wrap around the α-subunit and form a “seat-belt” struc-
ture important for the binding of the heterodimer to the receptor (Dias 2002, 
Moyle and Campbell 1996, Fan and Hendrickson 2005a, 2005b). 
The α-subunit contains 10 cysteines involved in the forming of disulphide 
bonds within the subunit that is critical for its interaction with the β-subunit 
(Sato et al. 1997, Hiro’oka et al. 2000). In FSH β-subunit, three cysteine pairs 
(cysteines 3 and 51, 28 and 82, 32 and 84) form the cystine knot that is required 
for the subunit folding and heterodimer assembly (Figure 2, Fan and Hendrick-
son 2005b). Region between cysteines 88 and 104 has been shown to prevent 
binding to LH receptor, thus being responsible for the receptor binding speci-
ficity (Figure 2). 
It has been established that FSH exists in circulation as a population of 
multiple glycoforms (isoforms) differing in carbohydrate chain composition, 
molecular weight and isoelectric point (pI) (Baenziger et al. 1988, Stockell-
Hartree and Renwich 1992, Stanton et al. 1996). The functional heterodimeric 
FSH contains two N-linked glycosylation sites on the α-subunit (Asn52 and 
Asn78) and two carbohydrates on the β-subunit (Asn7 and Asn24) added post-
translationally (Figure 1, Figure 2). The oligosaccharides that are attached to 
asparagine residues on the α- and β-subunits are major structural components 
comprising up to one third of the FSH mass (Dias 1996, Fox et al. 2001). It has 
been shown that the composition, structure and branching complexity of carbo-
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hydrate chains attached to FSH αβ-heterodimer determine intracellular behaviour 
of the hormone (Barrios-De-Tomasi et al. 2002, Ulloa-Aguirre et al. 2003). 
 
 
 
Figure 1. A, B Ribbon diagram of the human FSH bound to FSHR (Fan and Hendrick-
son 2005b). The structure is shown in two views related by a 90o rotation about the 
vertical axis. FSH α-chains and β-chains are in green and cyan, respectively. FSHR is in 
red. The observed N-linked carbohydrates at N52 and N78 of FSH-α, N7 and N24 of 
FSH-β, and N191 of FSHR are in yellow. Disulphide bonds are in black. 
C Pattern of glycosylation of FSH subunits (Rozell and Okrainetz 2009). 
 
 
 
Figure 2. Amino acid sequences of the FSH β-subunits in selected vertebrate species. 
Positions are numbered according to mature FSH β-subunit peptide. Only those amino 
acid residues that are different from the human FSH β-subunit are shown. Human FSHB 
peptide signal sequence is boxed. Highly conserved cysteine (involved in disulfide 
bonds formation) and asparagine residues are marked by shaded boxes. N-linked 
glycosylation sites are marked by black inverted triangles. Residues implicated in 
binding specificity are marked by asterisks. Alignment performed with EBI ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
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Human pituitary demonstrates two major FSH isoforms differing in glyco-
sylation patterns, tetra-glycosylated and di-glycosylated FSH glycoforms. The 
former type has both α- and β-subunits oligosaccharides, whereas the latter pos-
sesses only α-subunit oligosaccharides (Ulloa-Aguirre et al. 1995, Walton et al. 
2001). FSH α-subunit carbohydrates were shown to be essential for αβ-
heterodimer stabilisation and signal transduction (Flack et al. 1994, Bishop et 
al. 1994, Bousfield et al. 2007). Non-glycosylated FSH β-subunit that doesn’t 
have any attached carbohydrates comprised 60–65% and 50–60% of both 
healthy male and female (aged 21–43), and postmenopausal female (aged 71–
77) total FSHβ produced in pituitary, respectively (Bousfield et al. 2007). 
Glycosylated FSH β-subunits of tetra-glycosylated FSH isoform differ in 
their oligosaccharide chain structure. Oligosaccharides terminate with sialic 
acid and/or sulfonated N-acetylgalactosamine (GalNAc) that both are negatively 
charged. The amount of negatively charged residues has been shown to range 
from four to ten, whereas about 86% of FSH isoforms have 6–8 negatively 
charged groups (Wide et al. 2007). More acidic forms having increased 
sialyation and decreased sulfonation has been demonstrated to increase the half-
life of the hormone in the circulation and reduce the bioactivity of the FSH at 
the target organ (Perlman et al. 2003, Wide et al. 2009). The amount of more 
acidic FSH isoforms has been found to be the highest in males and post-
menopausal women, whereas less negatively charged, basic FSH isoforms, are 
more prevalent during midcycle and luteal phase of healthy women’s menstrual 
cycle (Zambrano et al. 1995, Wide and Bakos 1993, Wide et al. 2007). Andro-
gens have been shown to modulate the incorporation of sugar residues and 
favour the synthesis of acidic isoforms of FSH (Rulli et al. 1996). 
 
1.1.2.3 Follicle-stimulating hormone receptor 
Human follicle-stimulating hormone receptor (FSHR) shares 25–69% amino 
acid homology with luteinizing hormone/chorionic gonadotropin receptor 
(LHCGR) and thyroid-stimulating hormone receptor (TSHR), respectively. 
Transmembrane domains (TMs) of the glycoprotein hormone receptors display 
the highest homology (approx. 70%), whereas extracellular domains have lower 
homology (approx. 40%) (Simoni et al. 1997). It has been determined that 
receptor-ligand binding specificity is mediated by both the common α-subunit 
and extracellular domains of hormone-specific β-subunits (Dias and Van Roey 
2001, Fan and Hendrickson 2005a).  
The human FSHR consists of 695 amino acids, with the first 17 amino acid 
encoding a signal sequence (Gromoll et al. 1994, Simoni et al. 1997, Dias et al. 
2002, Themmen and Huhtaniemi 2000, Fan and Hendrickson 2005b). Mamma-
lian FSHRs demonstrate the highest amino acid homology in α-helical TMs 
(90%). Among species, extracellular NH2-terminal domain and intracellular 
COOH-terminal segment sequence similarity ranges 80–85% (Simoni et al. 
1997). Transmembrane helices are linked by intracellular loops (iLs). The latter 
structures have been shown to be crucial for G protein-coupling and signal 
transduction (Sairam and Babu 2007). Triple mutation introduced to iL3 
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affected FSHR structure and resulted in a complete inability to bind the receptor 
to G protein (Ulloa-Aguirre et al. 2007a). Large, glycosylated extracellular 
domain contains several leucine-rich repeats essential for ligand binding selec-
tivity. The mutation of two amino acids in extracellular domain allows binding 
with LH in addition to FSH (Smits et al. 2003).  
Hormone-receptor binding activates FSHR-bound heterodimeric Gs protein 
causing its dissociation into two molecules, the α-subunit and the β/γ-hetero-
dimer. The α-subunit stimulates adenylyl cyclase that causes the elevation of 
intracellular cAMP, activation of protein kinase A (PKA), phosphorylation of 
transcriptional regulator elements including the cAMP regulatory element-
binding protein (CREB), and transcriptional activation of specific genes (Means 
et al. 1976, Hunzicker-Dunn and Maizels 2006, Ulloa-Aguirre et al. 2007b). 
Additionally, cAMP-activated PKA acts on other downstream signalling path-
ways (e.g. mitogen-activated protein kinase (MAPK) and ERK1/2 cascades) 
involved in regulation of steroidogenesis, cell proliferation and survival 
(Pasapera et al. 2005).  
FSH also activates cAMP-independent cellular signalling cascades, e.g. 
pathways involving protein kinase B (PKB), phosphoinositide 3-kinase (PI3K), 
Rous sarcoma oncogene (SRC) family tyrosine kinase (SFK), and other specific 
kinases (Gonzalez-Robayna et al. 2000, Brock et al. 2003, Wayne et al. 2007).  
Additionally, FSH promotes phosphorylation or acetylation of histones as-
sociated with promoters of several FSH-target genes (e.g. inhibin-α, serum gluco-
corticoid kinase (SGK), c-FOS) causing chromosome remodelling and gene ex-
pression activation (Hunzicker-Dunn and Maizels 2006, and references therein). 
 
 
 
1.1.3. Function and regulation of secretion of gonadotropins 
1.1.3.1 The role of gonadotropins in hypothalamic-pituitary-gonadal axis 
LH and FSH act synergistically to control the production of gametes and steroid 
hormones in both sexes. Pituitary secreted LH and FSH are measurable in the 
human pituitary gland as early as the 10th week of gestation and during the 12th 
week in peripheral blood.  
In females, GnRH is secreted from the hypothalamus in a cyclical way 
leading to the pulsatile secretion of LH and FSH from anterior lobe of the 
pituitary gland, what maintains menstrual cycle. FSH targets ovarian follicle 
granulosa cells, stimulates the development of the ovarian follicle secretion of 
estradiol and progesterone. LH acts via receptors located on ovarian granulosa 
and theca cells and promotes the biosynthesis and secretion of androgen 
substrates that are converted to estradiol by granulosa cells (Figure 3). In males, 
GnRH causes the release of LH and FSH from the anterior pituitary, as in fe-
males. It was suggested that due to androgen exposure during embryonic 
development, different anatomical organization and functionality of hypo-
thalamic GnRH system, and differential use of signal transduction pathways, 
the reproductive function of males demonstrates less responsiveness to GnRH 
pulsatility (Bliss et al. 2009, Bliss et al. 2010 and references therein). LH binds 
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to the receptors located on Leydig cells of the testicular interstitium and stimu-
lates the production of testosterone that acts with FSH to regulate and maintain 
spermatogenesis. 
The functional role of combined action of LH and FSH in gonadal develop-
ment and reproduction was studied in mice deficient for GnRH (Mason et al. 
1986) or for the common α-subunit of gonadotropins (Kendall et al. 1995, Stahl et 
al. 1999). Male and female mice, deficient for the α-subunit, demonstrated infer-
tility, hypogonadism, and undetectable gonadal steroids level due to the absence 
of biologically active heterodimeric pituitary gonadotropins. GnRH-deficient 
mice never enter puberty and display a persistent hypogonadotropic-hypogonadal 
phenotype (Mason et al. 1986, Bouligand et al. 2010). Humans with naturally-
occurring disease, Kallmann syndrome (KS), resulting from the impaired GnRH 
signalling due to disturbances in hypothalamic GnRH neurons development, are 
infertile and demonstrate hypogonadotropic hypogonadism (Bliss et al. 2010).  
In males and females, FSH stimulates the production of gonadal inhibin, 
which has a negative feedback effect on the hypothalamus and pituitary (Figure 
3). The sex steroids inhibit release of GnRH and therefore LH and FSH (nega-
tive feedback). However, at high levels estradiol has positive feedback effect 
causing an increase in LH secretion and ovulation (LH surge). 
 
 
 
Figure 3. The hypothalamic-pituitary-gonadal (HPG) axis in males (left panel) and 
females (right panel). (-): negative feedback; (+): positive feedback  
 
 
hCG is produced during pregnancy and its principal function is to prepare endo-
metrium for the implantation and placentation, and to support early pregnancy 
(3–6 weeks of gestation) by promoting progesterone production in corpus luteal 
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cells (Moyle and Campbell 1996). hCG (which, being a LH analog, also 
stimulates testicular testosterone production) is required for masculinisation of 
the male fetus (Weinbauer et al. 2010). 
 
1.1.3.2. The detailed function of FSH in males and females 
FSH receptors are located on granulosa cells in females and on Sertoli cells in 
males. The necessity for FSH in females has been clearly established both in 
animal and human models. In female mammals, FSH stimulates the development 
of follicles that have resumed meiosis. During early stages of folliculogenesis, 
FSH is essential to prevent granulosa cells apoptosis and to stimulate granulosa 
cell proliferation, estradiol production and LH receptor expression (Chun et al. 
1996, Richards 1994). Expression of several gene products including aromatase 
and inhibin-α have been shown to be induced by cAMP/PKA/CREB pathway in 
granulosa cells (Lambard et al. 2005, Andrieu et al. 2009). Granulosa cells 
respond to FSH by up-regulating estrogen-metabolizing aromatase CYP19A1 and 
17-hydroxysteroid dehydrogenase (HSD17B1) resulting in increased estradiol 
synthesis. The estrogen rise via hypothalamic-pituitary feedback mechanisms 
leads to the release of LH (LH surge), terminating of preovulatory follicle growth, 
and initiation of ovulation (Edson et al. 2009). 
FSH β-subunit as well as FSH receptor-deficient female mice phenotype is 
similar to human ovarian dysgenesis syndrome that have arisen due to a defective 
FSH-receptor signalling (Aittomäki et al. 1995, 1996). Female mice lacking FSH 
exhibited infertility, small ovaries, block in folliculogenesis, defects in granulosa 
cell proliferation, and suppressed aromatase secretion (Kumar et al. 1997, Abel et 
al. 2000, Huhtaniemi 2006). FSH β-subunit deficient mice ovaries contained all 
early developmental stages of follicles, responded to exogenous gonadotropins 
and produced oocytes (Kumar et al. 1997, Burns et al. 2001).  
In contrast, FSH β-subunit deficient male mice were fertile, although they 
displayed decreased Sertoli cell number, reduced testes size, sperm count and 
motility (Kumar et al. 1997, Wreford et al. 2001). FSH acts as a primary 
mitogen on Sertoli cells stimulating the mitotic proliferation of immature Sertoli 
cells during fetal and early neonatal development. In the rat, suppression of 
FSH levels during this period of development resulted in a reduction of Sertoli 
cell numbers and thereby testicular size, and this effect was reversed by 
administration of FSH (Means et al. 1976, Orth et al. 1988). In addition to the 
direct effect on reproductive function via Sertoli cells, FSH regulates the pro-
duction of different mitogens (e.g. growth factors, cytokines) that have stimu-
latory effect on Leydig cells growth, activity and survival (O’Shaughnessy et al. 
1992, Matikainen et al. 1994, Baker et al. 2003). In adults, combined action of 
FSH and LH/testosterone is needed to support spermatogenesis and full fertility. 
Both in monkeys and adult human males, long-term immunization against FSH 
caused suppression of sperm production and testicular regression (Moudgal et 
al. 1992, Moudgal et al. 1997, Krishnamurthy et al. 2000). Treatment with 
recombinant FSH induces prepubertal testis growth in human prepubertal males 
exhibiting hypogonadotropic hypogonadism (Raivio et al. 2007).  
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In addition to the direct effect of FSH on fertility potential through FSH-
specific receptors located on the plasma membrane of the Sertoli cells and gra-
nulosa cells, recent studies in the ovary have suggested that circulating pituitary 
gonadotropins (LH and FSH) and testosterone mediate the activity of hormonally 
sensitive micro-RNAs thereby having an effect on postranscriptional gene 
regulation (Fiedler et al. 2008, Yao et al. 2009). Furthermore, it was established 
that FSH plays a key role in the regulation of apoptotic pathways during 
spermatogenesis supporting survival of spermatogonia and sperm release (sper-
miation) in normal adult men (van Alphen et al. 1988, Ruwanpura et al. 2008) 
Additionally, it was shown that FSH contributes to the genesis of peri-meno-
pausal and early post-menopausal bone loss by either direct binding to FSH 
receptors on osteoclasts or mediating the production of bone-modulating factors 
by immune cells (Sun et al. 2006, Iqbal et al. 2006, Sun et al. 2010). However, 
other studies failed to detect any expression of FSH receptors in bone 
preparations and showed that elevated FSH rather increases bone mass in 
female mice (Allan et al. 2010). No direct effect of FSH on male bone mass was 
observed (Ritter et al. 2008). 
 
1.1.3.3. Clinical conditions related to abnormal FSH production/level 
The measurement of serum levels of FSH and LH in combination with testo-
sterone is widely used in the diagnosis of development and reproduction distur-
bances. FSH level determination is primarily used for assessment of fertility 
potential and gonadal function. A normal serum FSH level suggests normal 
gonadal function. 
An extremely low or undetectable serum FSH concentration both in males and 
females may mirror a congenital problem at the level of either hypothalamus or 
pituitary. Patients with isolated hypogonadotropic hypogonadism (IHH) and 
Kallmann syndrome (KS) exhibit hypogonadism due to disturbed hypothalamic 
secretion or action of GnRH resulting in impaired secretion of pituitary gonado-
tropins, FSH and LH (Behre et al. 2010). Other congenital pathophysiological 
conditions featuring low FSH concentrations include Prader-Willi syndrome, 
fertile eunuch syndrome, and combined pituitary hormone deficiency due to rare 
mutation in PROP1 gene (Behre et al. 2010, Wu et al. 1998). Tumor of the 
pituitary gland may also be a cause of low serum FSH levels.  
The margins of male and female physiologically normal FSH levels change 
throughout the life periods. Before and during puberty, the concentrations of 
serum FSH are comparable in males and females, and range 0‒5.0 IU/mL and 
0.3‒10.0 IU/mL, respectively (Andersson et al. 1997). In adult males, normal 
concentration of serum FSH is ≤ 7 IU/L (following Ahda et al. 2005). However, 
one should consider other diagnostic indicators such as testes volume, sperm 
concentration and sex hormone ratios. High FSH levels in the presence of small 
(<6 mL) firm testes and azoospermia are characteristics of Klinefelter syndrome 
(47, XXY) (Simoni and Nieschlag 2010). Aging men exhibit the age-related 
changes in testicular spermatogenic function accompanied by a compensatory 
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increase (up to two-fold) in FSH level allowing for Sertoli cell function and 
spermatogenesis (Johnson 1989, Mahmoud et al. 2003, Rolf et al. 2010). 
In women of reproductive age, normal serum FSH levels vary considerably 
during different times of the menstrual cycle (4–13 IU/L) being the highest during 
follicular phase and late luteal phase. Polycystic ovary syndrome (PCOS) 
characterized by subnormal FSH levels represents a disruption of cyclic ovarian 
function with unbalanced LH to FSH ratio and excessive androgen production 
(Knuth 2010, Goodarzi et al. 2011). Congenital developmental issues leading to 
elevated FSH levels include developmental failure or absence of one or both 
ovaries (ovarian agenesis) and Turner’s syndrome (45, X). Women with normally 
induced perimenopause and menopause as well as patients exhibiting premature 
ovarian insufficiency have elevated FSH levels due to impaired ovarian response 
to the FSH-stimulation (Burger et al. 2008, Nelson 2009, Knuth 2010). 
FSH-secreting pituitary gonadotroph tumors may also be a cause of elevated 
FSH level accompanied by hypopituitarism, headaches and visual changes both 
in females and males (Young et al. 1996, Chaidarun and Klibanski 2002). 
Gonadotrope adenomas (gonadotropinomas) primarily produce heterodimeric 
FSH but may also secrete high levels of α-subunit and free β-subunits. Since 
unassociated FSH subunits don’t exhibit biological activity, adenomas secreting 
free subunits usually show no biological activity (Melmed 2008, Behre et al. 
2010). A few reports of gonadotropinomas secreting intact FSH and LH 
describe various clinical fertility phenotypes including precocious puberty and 
increased sperm counts in 7-year-old boy along with increased testes volume, 
infertility and hypogonadism in adult males (Young et al. 1996, Heseltine et al. 
1989, Zárate et al. 1986, Ambrosi et al. 1990). Women diagnosed with FSH-
secreting adenomas present with ovarian hyperstimulation syndrome (OHSS), 
menstrual cycle disturbances, low LH levels, and either normal or elevated 
estradiol levels (Shimon et al. 2001, Roberts et al. 2005, Cooper et al. 2008, 
Baba et al. 2009, Gryngarten et al. 2010). 
 
 
1.2. The genetics of gonadotropins  
(partially covered in Ref. I) 
1.2.1. Gonadotropin α-subunit coding gene (CGA)  
In human, the common α-subunit of glycoprotein gonadotropin hormones is 
encoded by a single gene (CGA, MIM 118850, 6q12–q21) spanning a region of 
9603 basepairs. In some species of fish two types of α-subunit have been 
identified that are coded by different genes. The organization of both α-subunit 
coding genes was identified to be similar to the mammalian α-subunit coding 
genes (Itoh et al. 1990, Huang et al. 1992).  
No human germ-line mutations in the CGA gene encoding for the common 
α-subunit have been described. One mutant form of the α-subunit was described 
that was ectopically secreted by a patient with carcinoma (Nishimura et al. 
1986). The mutant form co-existed with functional form of α-subunit and had 
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one amino acid substitution in exon 3 (Glu56Ala). The mutation resulted in 
higher molecular weight and structural changes that lead to incapability of 
combining with at least LH β-subunit. 
 
 
1.2.2. Follicle-stimulating hormone β-subunit coding gene 
FSH β-subunit coding gene is highly conserved across species (Figure 4). 
Molecular phylogenetic analyses of mammalian Fshb genes revealed five 
regions of highly conserved sequence homology: the proximal 5’ promoter 
region, exon 2, the 5’ translated region of exon 3, and two regions at the 3’ un-
translated end of exon 3 that include putative polyadenylation and transcrip-
tional termination signals (Figure 4, Kumar et al. 2006). Human FSHB gene 
genomic sequence shares 98% and 85% nucleotide similarity with chimpanzee 
(Pan troglodytes) and mouse (Mus musculus), respectively (Figure 4). Nucleo-
tide identity with zebrafish (Danio rerio) is 55%.  
 
 
 
Figure 4. Comparative alignment of FSH β-subunit gene sequence from selected 
vertebrate species. Only regions with sequence similarity >70% are coloured. Reference 
sequence is human FSH β-subunit coding gene (GenBank genomic sequence accession 
number NC_000011.9). Horse, Equus caballus, NC_009150.2; Mouse, Mus musculus, 
NC_000068.6; Rat, Rattus norvegicus, NC_005102.2; Dog, Canis lupus familiaris, 
NC_006603.2; Chicken, Gallus gallus, NC_006092.2. Alignment and visualization were 
performed with Genome Vista tools (http://genome.lbl.gov/vista/index.shtml). The 
identity curve is calculated as a windowed-average identity score for the alignment. A 100 
basepair-sized window is slid across the alignment and a score is calculated at each base in 
the coordinate sequence. Thus, the score for every point along the axis is the percentage of 
exact matches between the two alignments in a 100 bp-wide window centred on that point. 
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The genomic organization of the FSH β-subunit coding gene conforms to the 
pattern observed for other glycoprotein hormones β-subunit genes, and contains 
three exons and two introns (Figure 5). The similar exon-intron structure has 
been reported in mammals, birds and teleosts (Jameson et al. 1988, Gharib et al. 
1989, Guzman et al. 1991, Kim et al. 1988, Kumar et al. 1995, Rosenfeld et al. 
2001, Kawasaki et al. 2003).  
Human FSH β-subunit coding gene (FSHB, MIM 136530, genomic length 
4262 bp) is located on chromosome 11p13 (Figure 5, Watkins et al. 1987). This 
genomic region is characterized as AT-rich and gene-poor region. The average 
GC-content in FSHB gene is approximately 36%, what is 20% lower compared 
to the average GC-content obtained from the analysis of 74 human genes (45%) 
(Crawford et al. 2004). FSHB GC-content varies from 43–52% in exonic re-
gions to 30–33% in introns. The closest genes to FSHB, C11orf46 and KCNA4, 
are located 89.3 kilobases downstream and 214 kilobases upstream of the FSHB 
gene, respectively. 
 
 
 
 
Figure 5. Schematic representation of the (A) genomic context, (B) structure of the 
FSHB gene and (C) FSH β-subunit protein. Grey and white boxes indicate translated 
and untranslated parts of exons E1-E3, respectively. FSH β-subunit protein non-syno-
nymous changes causing clinical consequences are indicated with open triangles and 
polymorphism with a distinct phenotype is marked with black circle (detailed expla-
nation see from text and Table 4). 
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Differently from other members of glycoprotein hormone β-subunit gene 
family, the FSHB gene structure allows alternative splicing and polyadenylation 
to produce four forms of FSHB mRNA (Jameson et al. 1988). Untranslated 
exon 1 contains an alternate splicing donor site which cause transcripts to have 
different lengths of 5’ untranslated regions (5’ UTR). It was demonstrated that 
approximately 35% of FSHB transcripts have 33 bases in their 5’UTR and 65% 
of transcripts have 63 bases in the 5’UTR. In addition to the differences in 5’ 
UTR composition, there are also differences in the length of poly-A tail at the 3’ 
untranslated region of the FSHB gene where four consensus polyadenylation 
signals (AAUAAA) were predicted. One polyadenylation signal coincides with 
the stop codon in exon 3, three additional sites is located 1–1.2 kilobases down-
stream of the stop codon resulting in longer 3’ untranslated region (UTR) that is 
absent in other members of glycoprotein hormone β-subunits gene family 
(Figure 4, 5). Approximately 80% of transcripts have long poly-A tail as a result 
of the usage of the most distal polyadenylation signal, whereas 20% of 
transcripts have short or no poly-A tail (Jameson et al. 1988, Manjithaya and 
Dighe 2004). Different lengths of the FSHB mRNA transcripts may affect 
translational binding with the ribosome and, consequently, protein synthesis and 
also the stability of the transcripts within the gonadotrophs (Jameson et al. 
1988, Stanton et al. 2000).  
 
 
1.2.3. Genetic variation pattern of the human FSHB gene 
1.2.3.1. Human FSHB gene common diversity 
Although multiple animal and naturally occurring human models have indicated 
that FSH and FSH β-subunit gene are essential for full fertility, there are few 
studies on FSHB gene sequence inter- and intrapopulational genetic diversity as 
well as possible associations of common variants with phenotypic traits.  
In the study focused on the proximal part (‒489 bp relative to transcription 
start-site) of the promoter and translated area of the FSHB gene, three silent 
exonic and two intronic polymorphisms were identified (Lamminen et al. 
2005). The rarity of polymorphisms in the FSHB gene region is consistent with 
central roles of FSHB gene in reproduction. In contrast to FSHB, in the genes 
coding for LH and hCG β-subunits (LHB/CGB gene cluster), the high density of 
polymorphic position was detected (e.g. LHB gene, 1541 bp, 12 SNPs).  
Altogether, 27 nucleotide substitutions within the entire FSHB gene genomic 
sequence have been identified so far (Table 2, Table 3). Most of them localize 
to non-coding regions, introns and 3’-untranslated region of exon 3 (Table 2). 
Interestingly, no nucleotide substitutions have been mapped to FSHB exon 1. 
Three silent substitutions within the coding region of the gene have been 
identified (Table 3). Although synonymous changes do not affect protein 
sequence, they may co-exist with regulatory sequence variations. FSHB rs6169 
located in exon 3 (+2623 bp from TSS, C/T, 58 Tyr ⇒ Tyr) has been suggested 
to be associated with polycystic ovarian syndrome (PCOS) on obese Chinese 
women (Liao et al. 1999, Tong et al. 2000). Allele frequency distribution of this 
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polymorphism showed population-specific differences ranging from 33.3% to 
59.5% in Malays and Danish populations, respectively (Liao et al. 1999, 
Lamminen et al. 2005). Recently, in a large-scale gene association study 
focused on the genes related to steroid-hormone metabolism and breast cancer 
risk, FSHB rs6169 showed no association with susceptibility to the malignancy 
of mammary gland (Canzian et al. 2010). However, in another candidate gene 
association study, the same position was significantly associated with age at 
menarche (He et al. 2010).  
 
 
Table 2. Known genetic variants within untranslated regions of the FSHB gene (intron 
1, intron 2, exon 3 3’UTR) based on dbSNP Build 132 (http://www.ncbi.nlm.nih.gov/ 
projects/SNP/). Nucleotide positions are defined according to the location of the 
transcription start-site in the genomic DNA sequence (NC_000011.9).  
 
Location  rs number Nucleotide 
substitution 
Location  rs number Nucleotide 
substitution 
intron 1 613058 G342T intron 2 78130864 A1778G 
 118067137 A595G  77193389 C1792T 
 35298877 A597T  34259552 T1847– 
 34394185 A605T  74566831 A1870G 
 550312 T627G  595496 T1988C 
 611246 T756A  594982 C2121A 
 111823008 T840C  112303897 A2176G 
intron 2 35235566 G1047–  76152907 G2218T 
 609896 T1079C  115600568 C2460T 
 80319222 A1145C  506197 G3261A 
 35536959 T1430G exon 3 3’UTR 506306 G3305C 
 34279061 A1476G  676349 A3420G 
 34922768 C1600T  78946483 T3733G 
 580646 T1706G  75464895 G3794A 
–, deletion 
 
 
1.2.3.2. FSHB gene mutations with clinical phenotype 
Genetic alterations in the structure of FSH β-subunit have dramatical effects on 
fertility further supporting the critical roles of FSH. As yet, only five naturally 
occurring inactivating mutations of FSHB gene have been reported in three 
male and six female patients. Three mutations in exon 3–Val61Δ2bp/87X, 
Tyr76X, and Ala79Δ1bp/108X–lead to a premature stop codon and truncation 
of the FSH β-subunit protein (Figure 5, Table 3) (Matthews et al. 1993, Layman 
et al. 1997, Phillip et al. 1998, Berger et al. 2005, Lofrano-Porto et al. 2008, 
Kottler et al. 2010). Two other mutations identified in exon 3, Cys51Gly and 
Cys82Arg, result in a loss of a cysteine residue that prevent a formation of a 
cysteine knot structure within the β-subunit peptide (Figure 5, Table 3) (Lay-
man et al. 1997, Lindstedt et al. 1998).  
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Patients homozygous for FSHB gene mutations exhibited absent or in-
complete pubertal development and infertility due to the absence of heterodi-
meric FSH. Male and female patients demonstrated azoospermia and lack of 
follicular growth and differentiation, respectively. However, compound hetero-
zygous mutation (Val61X/Cys51Gly) carrier’s relatives that were heterozygous 
for the mutation Cys51Gly were fertile, indicating that a single normal copy/ 
allele of FSHB gene is sufficient to produce biologically active FSH (Layman et 
al. 1997). 
One non-synonymous nucleotide substitution within FSHB exon 2 with 
unknown phenotypic consequence was identified (rs6170, G/T, Ser/Ile; Cargill 
et al. 1999). 
 
 
Table 3. Non-synonymous genetic variants in the translated part of the FSHB gene. 
Nucleotide positions are defined according to the location of the transcription start site 
in the genomic DNA sequence (NC_000011.9). Amino acid positions are defined based 
on the sequence of mature protein (NP_000501.1). Non-synonymous inactivating muta-
tions are indicated in bold. 
 
Location  rs number Nucleotide 
substitution 
Codon 
substitution 
Amino acid 
substitution 
Reference 
exon 2 6170 G946T AGC ⇒ ATC 2 Ser ⇒ Ile Cargill et al. 1999 
exon 3 36206707 G2460A AAG ⇒ AAA 40 Lys ⇒ Lys Lamminen et al. 2005 
 5030776 T2600G TGT ⇒ GGT 51 Cys ⇒ Gly Layman et al. 1997 
 6169 T2623C TAC ⇒ TAT 58 Tyr ⇒ Tyr Liao et al. 1998 
 5030646 TG2631– GTG ⇒ G 61 Val fs ⇒ 87 X Matthews et al. 1993, 
Layman et al. 1997, 
Phillip et al. 1998 
 121909666 C2677A TAC ⇒ TAA 76 Tyr ⇒ 76 X Layman et al. 2002, 
Lofrano-Porto et al. 
2008, Berger et al. 
2005 
 na G2684– GCC ⇒ CC 79 Ala fs ⇒ 108 X Kottler et al. 2010 
 5030777 T2693C TGT ⇒ CGT 82 Cys ⇒ Arg Lindstedt et al. 1998 
 34365964 G2707A AAG ⇒ AAA 86 Lys ⇒ Lys Lamminen et al. 2005 
–, deletion; X, translational stop-codon; fs, frameshift; na, rs# is not available in the 
database 
 
 
1.2.4. The regulation of the FSHB gene expression 
Follicle-stimulating hormone and luteinizing hormone are both produced by 
gonadotropic cells within the anterior lobe of pituitary gland. The production of 
gonadotropin common α-subunit and hormone-specific β-subunits (LHβ and 
FSHβ), and secretion of mature pituitary gonadotropins are controlled by 
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synchronized pulses of gonadotropin-releasing hormone (GnRH) produced by 
hypothalamic neurons (Pawson and McNeilly, 2005). Since α-subunit is pro-
duced in excess of gonadotropin β-subunits, the expression level of the latters is 
rate-limiting factor for pituitary gonadotropin hormones production kinetics 
(McNeilly et al. 2003).  
It was determined that the secretion of α-subunit and LH β-subunit is the 
highest at GnRH pulse frequency 8 and 60 min, respectively, while lower pulse-
frequency (pulse interval 2 hours) of GnRH results in a decline in LHβ and rise 
in FSHβ production (Haisenleder et al. 1991, Kaiser et al. 1995, Ferris and 
Shupnik 2006, Lim et al. 2009). GnRH acts via its receptor (GnRHR) located 
on gonadotroph membranes and causes activation of G proteins, release of 
calcium from intracellular stores, and increase in the activity of protein kinase C 
(PKC). As a result, three mitogen-activated protein kinase (MAPK) pathways 
are activated (ERK, jun-N-terminal kinase (JNK) and p38). Different activity 
combinations of these MAPK pathways result in differential activation of α-
subunit, LHβ, and FSHβ coding genes expression (Vasilyev et al. 2002, Lim et 
al. 2009, Armstrong et al. 2010). MAP kinases activate different DNA cis-ele-
ments by phosphorylating their cognate transcription factors including activator 
protein-1 (AP-1) and cyclic AMP response element-binding protein (CREB) 
that are bound to GnRH responsive elements within the proximal part of gene 
promoter (Figure 6) (Wang et al. 2008, Ciccone et al. 2008, 2010; Bliss et al. 
2010). 
Additionally, epigenetic mechanisms of GnRH signalling have been sug-
gested in embryonic gonadotroph precursor cells. Histone modifying enzymes, 
histone deacetylases (HDACs), occupy FSHβ coding gene promoter repressing 
expression. GnRH causes expression of Nur77 gene product that phosphorylates 
and eliminates HDACs, thereby, inducing FSHβ gene expression (Lim et al. 
2007).  
Other cis-elements within FSHβ coding gene promoter were shown to bind 
steroidogenic factor-1 (SF-1), nuclear transcription factor Y (NFY), activin, 
steroid hormone receptors (Figure 6) (Thackray et al. 2006, Melamed 2010, 
Bernard et al. 2010, and references therein). Activin causes phosphorylation and 
binding of SMAD proteins to Sma- and Mad-related protein-binding elements 
(SBE-like 1 and SBE-like 2) within human FSHB promoter. This causes the 
induction of FSHB gene activity (Graham et al 1999, Bernard 2004, Suszko et 
al. 2005). Pituitary produced follistatin and gonadal inhibin both are able to 
repress the FSHβ coding gene expression by binding to activins and their 
receptors, respectively (Bernard et al. 2010 and references therein). 
 FSH β-subunit gene expression has been shown to be regulated by three 
steroid hormone receptors (glucocorticoid receptors, GR; progesterone receptor, 
PR, androgen receptor, AR) that bind to hormone response elements (HRE) 
located within FSH β-subunit gene promoter (Figure 6) (Burger et al. 2004, 
Thackray et al. 2006, 2010). Combination of steroid hormone with its receptor 
allows the phosphorylation and activation of the receptor, binding of the 
complex to HRE, and activation of transcriptional factors that alter gene 
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transcription. Single human polymorphic variant, rs10835638 G/T (‒211 bp 
from TSS, Figure 6), located within one of the HREs, HRE3, has been shown to 
be responsible for differential regulation of human FSHB expression in vitro 
(Webster et al. 1995, Hoogendoorn et al. 2003). 
Ligand-independent mechanism of steroid hormone receptor activation has 
been also reported. Alternative mechanism involves peptide growth factors, 
cAMP-dependent protein kinase, and cyclins that phosphorylate and activate 
steroid hormone receptors independently of steroid hormone action (Power et 
al. 1991, Cenni and Picard 1999, Levine et al. 2001). Gonadal steroids exert 
their actions also at the level of hypothalamus, by the regulation of GnRH 
secretion (reviwed in Melamed 2010, Bernard et al. 2010). 
Steroid hormones were also reported to modulate FSH β-subunit gene 
postranscriptionally by altering the stability of mRNA. In contrast to other 
members of the glycoprotein family, FSHβ mRNA has a long 3’UTR that was 
identified to regulate FSH β-subunit gene expression (Jameson et al. 1988, 
Kumar et al. 2006). Presence of long 3’UTR in bovine Fshb mRNA was shown 
to decrease association with translational ribosomal complex (Manjithaya and 
Dighe 2004). The phylogenetic analysis of FSH β-subunit coding gene 3’-
flanking region revealed high level of conservation (up to 90%) among mam-
malian species (Figure 4). Gonadotroph-specific expression of human FSHB 
gene with truncated 3’-flanking sequence demonstrated the presence of genetic 
elements required for efficient gene expression (Kumar et al. 2006). Several 
AU-rich elements located within 3’UTR of FSH β-subunit encoding gene are 
capable of interacting with various trans-factors including steroid hormone 
receptors and ELAV family proteins (e.g. HuR protein) (Peng et al. 1998, Ing 
2005). Additionally, AU-rich regions form complex stem-loop structures which 
may affect protein expression (Samaddar et al. 1999).  
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Figure 6. The alignment of proximal part (400 bp from the transcription start-site) of 
Fshb/FSHB promoters in pig, sheep, human, mouse, and rat. Transcription start-site is 
marked with horizontal arrow. The Fshb/FSHB gene promoter cis-elements (described 
in the text) are labeled and boxed. Nucleotides boxed in gray reflect differences from 
the experimentally defined cis-element. Hormone Response Element (HRE3) marked 
with red box and position –211 G were studied further in this thesis. Promoters were 
aligned using ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2/index.html). Modified 
from Bernard et al. 2010. 
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2. AIMS OF THE PRESENT STUDY 
The present thesis represents a focused research on the follicle-stimulating hor-
mone β-subunit coding gene (FSHB). Specific aims of the study are as follows: 
 
 to survey the fine-scale genetic variation patterns of the FSHB gene in 
human worldwide populations (Estonians, Czechs, Utah Mormons/ 
CEU, Mandenkalu, Han Chinese, Koreans) 
 
 to determine the ancestral FSHB gene variant through comparative 
genomics approach using sequencing of the FSHB gene in great apes 
(chimpanzee, gorilla, orangutan)  
 
 to conduct a pilot-study investigating whether the identified human 
FSHB gene haplotypes may have functional consequence on female 
reproductive health 
 
 to perform in silico polymorphism screening in evolutionarily con-
served 5’- and 3’-flanking regions of the FSHB gene in order to identify 
putative polymorphic regulatory variants 
 
 to perform quantitative genetic association analyses between FSHB 
promoter polymorphism (‒211 G/T, rs10835638) and male reproduc-
tive parameters in the population-based Baltic cohort of young men 
(Estonians, Latvians and Lithuanians) and Estonian cohort of males 
diagnosed with infertility. 
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3. RESULTS 
3.1. The fine-scale sequence diversity of the follicle-
stimulating hormone β-subunit coding gene (FSHB)  
(Ref. I, II) 
3.1.1. The variation pattern of the FSHB gene across populations 
originating from three continents 
In order to determine the human population variation of the FSHB gene, I have 
studied six populations originated from Europe (Estonians, Czechs, Utah 
Mormons/CEU), Africa (Mandenkalu), and Asia (Han Chinese, Koreans) 
(Table 4). The FSHB gene genomic sequence (2909 bp) was re-sequenced in 
Estonians, Mandenkalu and Han Chinese. Czechs, Koreans and Utah Mormons/ 
CEU were studied by combining partial re-sequencing and Restriction Fragment 
Length Polymorphism (RFLP) analysis approaches (Table 4). 
 
 
Table 4. Methodology, analyzed region of the FSHB gene, and population samples used 
in the study of the FSHB gene fine-scale variation. 
Method Analyzed region description Population sample 
No of 
individuals 
full re-
sequencing 
2909 bp (+407...+3316 bp relative to TSS): 
456 bp of intron 1, translated parts of 
exonic regions (exon 2, 165 bp; exon 3, 
231 bp), intron 2 (1508 bp), 549 bp of exon 
3 3’-UTR 
Estonians 
(Europe)a 
48 
Mandenkalu 
(Africa)b 
24 
Han Chinese 
(Asia)b 
25 
combined 
approach  
(i) partial re-sequencing (748 bp, 
+407…+1155 bp relative to TSS): 
456 bp of intron 1, exon 2 (165 bp), 127 bp 
of exon 2, and  
 
(ii) RFLP analysis (rs594982, position 
+2121; rs6169, position +2623) 
Czechs 
(Europe)c 
50 
Korean 
(Asia)d 
45 
unrelated Utah 
Mormons/ CEU 
(Europe)b,e 
30 
TSS, transcription start-site 
a Anonymous population-based cohort originated from the DNA bank of the Depart-
ment of Biotechnology, Institute of Molecular and Cell Biology, Tartu University, 
Tartu, Estonia  
b Samples were obtained from the HGDP-CEPH Human Genome Diversity Cell Line 
Panel (http://www.cephb.fr/HGDP-CEPH-Panel/ ; Cann et al. 2002). 
c Samples shared by Dr. Viktor Kozich (Charles University First Faculty of Medicine, 
Institute of Metabolic Disease) 
d Samples shared by Dr. Woo Chul Moon (Good-Gene Inc. Seoul, Korea) 
e Unrelated Utah residents (USA) with Northern and Western European ancestry 
(http://www.cephb.fr/HGDP-CEPH-Panel/; Cann et al. 2002). 
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No non-synonymous changes have been identified within translated part of the 
FSHB gene in the analysed individuals. In total, 2909 bp re-sequenced region 
contained 12 SNPs (SNP density = 4 per kb): seven common polymorphisms 
(MAF>10%) spread in all populations and five rare singleton variants present 
on a single chromosome in a population (Table 5; Figure 7A; Supplementary 
Tables S2, S3 in Ref. II). Most identified polymorphisms were located within 
non-coding gene regions, two synonymous changes (T2623C, rs6169; G2707A, 
rs34365964) were found in translated part of exon 3 (Figure 7A). Additionally 
to common nucleotide changes, five rare nucleotide variants that were identified 
in only one population sample but absent in others have been identified. Exonic 
SNP rs34365964 detected in Estonian population in the current study has also 
been identified in heterozygote status in 8% of Finnish individuals (Lamminen 
et al. 2005). Intronic rs34279061 present in one Mandenkalu individual was 
further confirmed by the pilot-data from The 1000 Genomes Project 
(http://www.1000genomes.org/). Sequence variation data from the study was 
submitted to dbSNP under accession numbers ss49785048–ss49785060. 
 
 
 
Table 5. Minor allele frequencies (MAF) of the FSHB gene SNPs identified in the 
current study. 
 
Nucleotide 
changea Location 
dbSNPb  
rs no 
Minor allele frequency (MAF, %) 
Estonia
(n=48) 
Mandenka
(n=24) 
Han 
(n=25) 
Korea 
(n=45) 
Czech 
(n=50) 
Utah/ 
CEU 
(n=30) 
A597T intron 1 35298877 – – S – – – 
A605T intron 1 34394185 – S – – – – 
G627T intron 1 550312 44.7 37.5 24.0 36.7 51.0 70.0 
T756A intron 1 611246 42.6 33.3 20.0 35.6 52.0 70.0 
C1079T intron 2 609896 44.7 37.5 18.0 32.2 52.0 70.0 
T1430G intron 2 35536959 – – S na na na 
A1476G intron 2 34279061 – S – na na na 
G1706T intron 2 580646 43.6 35.4 18.0 na na na 
C1988T intron 2 595496 44.7 37.5 20.0 na na na 
C2121A intron 2 594982 41.5 27.1 18.0 32.2 52.0 70.0 
T2623C exon 3 6169 45.7 16.7 18.0 25.6 50.0 70.0 
G2707A exon 3 34365964 S – – na na na 
G3261A* exon 3 UTR 506197 na na na na na na 
a Relative to transcription start-site (GenBank Accession No. NC_000011.9, Appendix 3). 
b dbSNP Build 132 (http://www.ncbi.nlm.nih.gov/snp) 
*The position was identified in the Estonian, Mandenka and Han Chinese populations, 
but allele frequencies were not reliably determined. 
S = polymorphism present in single individual; n = no of individuals; na = not analyzed; 
‘–ʼ = SNP not identified 
 
 
Two estimators of nucleotide diversity have been calculated for Estonian, 
Mandenka and Han Chinese populations: (i) π, the direct estimate of per-site 
heterozygosity derived from the observed average pairwise sequence difference 
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among individuals and (ii) Watterson's θ, per-site heterozygosity based on the 
number of segregating sites. Among the studied populations, the FSHB gene 
nucleotide diversity (π) ranged from 0.00079 and 0.00123 (Table 6). FSHB 
gene overall diversity is comparable to human genome average based on the 
analysis of 1.42 million SNPs (π~0.00075) (Sachidanandam et al. 2001) and 
average per-site nucleotide diversity obtained from the re-sequencing of 74 
genes (π=0.0083) (Crawford et al. 2004), but is up to six-fold lower when 
compared to the results of LHB/CGB genes (Hallast et al. 2005). 
To investigate whether observed patterns of the FSHB gene diversity are 
consistent with the neutral model of molecular evolution (Kimura 1983), 
Tajima’s D (DT) (Tajima 1989), Fu and Li’s D (DFL), and Fu and Li’s F (FFL) 
(Fu and Li 1993) were calculated (Table 6). Tajima’s D is the difference 
between π and θ estimates. In case of neutrality, π equals θ, and thus DT statistic 
equals zero. Significant positive values of DT and FFL in Estonian and 
Mandenka populations (Estonians, DT=3.22, FFL=2.397; Mandenkalu, DT=2.52; 
FFL=1.938) signify excess of high-frequency SNPs and heterozygotes, indi-
cating the possible balancing selection and/or population subdivision. 
 
 
Table 6. FSHB nucleotide diversity parameters and neutrality tests. 
 
 Estonians Mandenkalu Han Chinese 
Sample size 47 24 25 
Diversity estimates and neutrality tests 
π1 0.00123 0.00109 0.00079 
θ2 0.00048 0.00056 0.00055 
Tajima’s D (DT) 3.224** 2.523* 1.130 
Fu and Li’s D (DFL) 1.198 1.244 1.242 
Fu and Li’s F (FFL) 2.397* 1.938* 1.416 
Estimation of per-site heterozygosity derived from  
1 the average pairwise sequence difference among individuals and  
2 the number of segregating sites per 1 bp (Watterson 1975) 
Significance of the statistical test: * p<0.05, ** p<0.01 
 
 
Pairwise linkage disequilibrium (LD) is the non-random association of alleles at 
two chromosomal loci. The amount of LD depends on the difference between 
observed and expected allele frequencies and is influenced by different factors 
including genetic linkage, selection, recombination and mutation rate, genetic 
drift, and population structure (Hudson et al. 2001, Pritchard and Przeworski 
2001). Two types of statistics can be applied to measure the extent of LD 
between pairs of loci: (i) standardized coefficient of LD (D’) (Lewontin 1964) 
and/or squared correlation coefficient r2 (Hill and Robertson 1968), and (ii) 
statistical significance of the correlation coefficient (chi-square test, Fisher’s 
exact test). 
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To examine patterns of LD within FSHB gene, squared correlation co-
efficient r2 and significance of LD correlation coefficient r2 for all pairwise 
comparisons of common polymorphisms (minor allele frequency, MAF > 0.1) 
was calculated using Arlequin 2.000 (Schneider et al. 2000) and Genepop 3.1d 
(Raymond and Rousset 1995). Squared correlation coefficient r2 equals 0 if two 
alleles are inherited randomly. The LD coefficient is considered statistically 
significant if p-value is less than 0.05.  
Allelic associations were significant throughout the gene for all studied 
populations (Estonians, p<0.001, 0.795<r2<1; Mandenkalu, p<0.001, 0.62<r2<1; 
Han Chinese, p<0.001, 0.53<r2<1). In order to study structure and frequencies 
of the FSHB gene haplotypes‒“blocks” of alleles on a chromosome that are 
always inherited together‒five SNPs (Figure 7A, B) were chosen to be analysed 
in additional populations (Table 4, Table 5). Two core FSHB gene haplotype 
variants (haplotype 1 and haplotype 2) composed of complementary nucleotides 
at all sites were identified (Figure 7B, C; Supplementary Tables S3, S4 in Ref. 
II). Among studied chromosomes (n=444), 96.6% of Utah, 96% of Czech, 
92.6% of Estonia, 86% of Han Chinese, 79.2% of Mandenka, and 76% of Korea 
FSHB gene haplotypes were represented by two core haplotypes. Haplotype 1 
was the prevalent haplotype for all populations except among Utah individuals. 
Haplotype 2 was enriched in populations of European origin (haplotype 2 
frequency in Estonians, 39.4%; Czechs, 48.0%; CEU, 68.3%) compared to non-
Europeans (Han Chinese, 14%; Mandenkalu, 16.7%; Koreans, 21%) (Figure 
 
 
3.1.2. Comparison of the FSHB gene sequence  
between human and great apes 
In order to study the differences between human and great apes FSHB genomic 
sequences, respective genomic region in chimpanzee (Pan troglodytes), gorilla 
(Gorilla gorilla) and orangutan (Pongo pygmaeus) was sequenced. The full 
sequences of great apes FSHB gene are deposited in NCBI GenBank (P. troglo-
dytes FSHB Acc. No. DQ302103, G. gorilla FSHB DQ304480, P. pygmaeus 
FSHB DQ304481). The similarity scores between human and great apes FSHB 
gene genomic sequence ranged 97–99% and 95–98% within exonic and intronic 
regions, respectively (Table 7). 
 
 
7C; Supplementary Table S4 in Ref. II). 
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Table 7. Sequence similarity scores (%) between human (H, Homo sapiens), chim-
panzee (C, Pan troglodytes), gorilla (G, Gorilla gorilla), and orangutan (O, Pongo 
pygmaeus) FSHB gene exonic (945 bp) and intronic (1964 bp) regions. Chimpanzee 
DNA was extracted from sperm material obtained from Tallinn Zoo, Estonia. The 
sources of orangutan and gorilla DNAs were primary cell lines AG12256 abd 
AG05151B, purchased from ECACC. 
 
Exons 
species H C G O 
Introns 
H – 98 98 95 
C 99 – 97 96 
G 98 98 – 96 
O 98 97 97 – 
 
 
In total, 11 nucleotide differences in great apes coding region of the FSHB gene 
relative to that of human have been identified, three of which cause amino acid 
changes (Table 8). One difference from Lys to Asn (exon 3, amino acid 64) was 
present in all studied great apes species, Leu to Val change (exon 2, amino acid 
4) in the signal peptide and Tyr to His change (exon 3, amino acid 49) were 
present in orangutan and chimpanzee, respectively. 
 
 
Table 8. Nucleotide differences in FSHB gene coding region between human and great apes. 
 
 Nucleotide 
difference1 
Amino acid 
difference2 
Signal (S) or 
mature (M) 
peptide 
Exonic 
location 
All studied great 
apes species3 
2587 AAA→AAC 64 Lys(K)→Asn(N) M exon 3 
2728 GAT→GAC 111 Asp (D)→Asp(D) M exon 3 
Chimpanzee 
(Pan troglogytes) 
1032 TAC→CAC 49 Tyr(H)→His(H) M exon 2 
2641 CCC→CCT 82 Pro(P)→Pro(P) M exon 3 
2746 CTG→CTA 117 Leu(L)→Leu(L) M exon 3 
Gorilla 
(Gorilla gorilla) 
2566 TAT→TAC 57 Tyr(Y)→Tyr(Y) M exon 3 
2734 ACT→ACC 113 Thr(T)→Thr(T) M exon 3 
Orangutan 
(Pongo pygmaeus) 
897 CTC→GTC 4 Leu(L)→Val(V) S exon 2 
986 GAA→GAG 33 Glu(E)→Glu(E) M exon 2 
2734 ACT→ACC 113 Thr(T)→Thr(T) M exon 3 
1 Nucleotide positions are defined relative to transcription start-site on the human FSHB 
gene genomic DNA sequence (GenBank, NC_000011.9, Appendix 3) 
2 Amino acid positions are defined based on the sequence of human FSH β-subunit 
preprotein containing signal peptide (GenPept, NP_000501.1) 
3 Nucleotide differences present in chimpanzee, gorilla and orangutan. 
 
 
Chimpanzee, gorilla and orangutan FSHB gene haplotype predicted from the 
positions of seven human common SNPs (Figure 7A) was identical among all 
studied species, except for a single basepair deletion in the orangutan gene for 
SNP rs611246 (Figure 7C; Table 2 in Ref. II). When compared to the human 
FSHB gene haplotypes, great apes FSHB haplotype is most similar to the 
second human FSHB core variant, haplotype 2, differing from the latter in two 
positions (rs594982 and rs6169) (Table 2 in Ref. II). 
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Figure 7. Identified variation pattern of the FSHB gene.  
(A) Human polymorphic positions (vertical arrows) identified within re-sequenced 
human FSHB region (2909 bp) in Estonians, Mandenkalu and Han Chinese. Coding 
exons (E2, E3) are indicated by boxes and translated sequence is denoted by grey area. 
Positions are shown relative to FSHB transcription start-site: red long arrows mark 
common SNPs (MAF>10%) and black short arrows mark rare SNPs (MAF<10%). Five 
tag-SNPs (marked with asterisks) were chosen for genotyping the Korean, Czech and 
Utah Mormon/CEU samples. Allelic status of positions +627 (rs550312), +756 
(rs611246) and +1079 (rs609896) was determined by re-sequencing approach; positions 
+2121 (rs594982) and +2623 (rs6169) were typed by RFLP analysis. 
(B) Definition of FSHB gene core haplotypes (haplotype 1 and haplotype 2) based 
on the genotyping of five SNPs. The allelic composition of the two FSHB gene variants 
differs in each polymorphic position shown as black circles. Haplotype 1 and haplotype 
2 correspond to the core haplotype 1 and core haplotype 13, respectively, in Ref. II 
(Table 2, Supplementary Material S4). 
(C) Median-Joining (MJ) network for predicted FSHB haplotypes. Haplotypes have 
been constructed based on five SNPs typed for three European (Estonia, Czech, Utah 
Mormon/CEU), two Asian (Han Chinese, Korea), and African population (Mandenka). 
Relationships between predicted haplotypes were investigated using the Median-Joining 
(MJ) network algorithm (Bandelt et al. 1999) within NETWORK 4.0 software. The size 
of each node is proportional to the haplotype frequency in the total dataset. Branch 
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lengths represent one nucleotide substitution. The relative distribution of each haplotype 
among individuals of non-European and European origin is indicated by grey and white, 
respectively. Banded FSHB haplotype refers to the FSHB haplotype identical to chim-
panzee (Pan troglodytes) and gorilla (Gorilla gorilla) gene variants. Orangutan (Pongo 
pygmaeus) had a deletion in the position +756 (rs611246), and orangutan’s FSHB 
haplotype is denoted by banded square. 
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3.1.3. A pilot-study on possible association of FSHB variants with 
reproductive success 
None of the FSHB gene polymorphisms identified in the study directly affects 
the composition and structure of the FSHB protein. However, the current study 
has determined that the FSHB gene has two genetic variants spread worldwide. 
The performed neutrality tests support the evidence that the gene has evolved 
under the influence of selection. FSH plays crucial role in maintaining of 
menstrual cycle in female allowing recruitment and growth of ovarian follicle. 
In order to explore the hypothesis that the FSHB core haplotypes might be 
associated with female fertility and reproductive health, a pilot-study for genetic 
association was performed. We asked whether the FSHB gene core haplotypes 
are distributed differently in the sample consisting of Estonian women who 
conceived naturally within three months after stopping contraception compared 
to random population-based Estonian women’s cohort. 
The FSHB gene was analysed in the sample of 48 Estonian women who had 
conceived within a period of three months after stopping contraception (Short 
Time to Pregnancy, STP-sample) (Table 9). The frequencies of homozygotes 
for haplotype 1 (HAP1/HAP1), heterozygotes (HAP1/HAP2) and homozygotes 
for haplotype 2 (HAP2/HAP2) were compared to those among unselected 
population sample of Estonian women (n=47) and unrelated Utah Mormon/ 
CEU individuals (n=30) (Table 9). The latter sample consisted of unrelated 
individuals from very fertile pedigrees, which were originally sampled to con-
sist of four grandparents, the two parents and at least eight children (collected 
by the Centre d'Etude du Polymorphisme Humain (CEPH), Dausset et al. 1990). 
The frequency of HAP1/HAP1 carriers was 21.3% in STP-women and 27.7% in 
the random population sample, whereas the prevalence of HAP2/HAP2 was 
34.0% in STP-group and 14.9% in the random population sample. HAP2/HAP2 
homozygotes were overrepresented among Utah Mormon/CEU individuals 
(40%). Most extremely, among Utah Mormon/CEU individuals, no HAP1/ 
HAP1 homozygotes were identified.  
Although none of the entire FSHB gene polymorphism/haplotype seems to 
directly affect FSHB protein, the second FSHB gene core variant, haplotype 2, 
was shown to be overrepresented among STP-sample as well as unrelated Utah 
Mormon/CEU individuals when compared to population-based Estonian women 
cohort. The enrichment of one of the gene variants might be a sign of the 
process of genetic hitchhiking by which functionally neutral allele/haplotype 
co-exists with a favourable regulatory variant (Barton 2000, Wall and Pritchard 
2003). Additionally, the differences between Estonian sample and CEU indivi-
duals both originating from Europe may refer to possible effects of population 
history, for instance, population subdivision (Barton 2000). Further studies with 
larger sample sizes are needed to investigate the detail role of the FSHB variants 
in shaping reproductive phenotypic diversity and fertility in women.  
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Table 9. The distribution of homo- and heterozygous individuals for FSHB gene haplo-
types in samples analyzed to investigate possible effects of FSHB haplotypes on 
reproductive function. The FSHB gene haplotypes were predicted based on FSHB gene 
positions rs594982 and rs6169. 
 
Sample no of individuals HAP1/HAP1 HAP1/HAP2 HAP2/HAP2 
Rare 
variants 
a population-based 
Estonian cohort  
(Ref. II) 
47 27.7% n=13 
46.8% 
n=22 
14.9% 
n=7 
10.6% 
n=5 
b STP-sample
(Ref. II) 48 
21.3% 
n=10 
42.6% 
n=20 
34.0% 
n=16 
4.3% 
n=2 
c unrelated Utah 
Mormon/CEU 
(Ref. II) 
30 60.0% n=18 
40% 
n=12 
not 
identified 
a Anonymous population-based female cohort representing general population. No 
phenotype data available (clinic: Tartu University Clinic, Tartu, Estonia; clinical coordi-
nator: Dr. Kristiina Rull) 
b Short Time to Pregnancy (STP) sample (see explanation in the text; clinic: Tartu 
University Clinic, Tartu, Estonia; clinical coordinator: Dr. Kristiina Rull) 
c Unrelated Utah residents (USA) with Northern and Western European ancestry (Cann 
et al. 2002; http://www.cephb.fr/HGDP-CEPH-Panel/). 
 
 
3.2. The putative regulatory loci  
in the FSHB gene flanking regions (Ref. III–V) 
3.2.1. Screening of genetic variation in conserved 3’- and  
5’- non-coding regions of FSHB gene 
Transgenic studies by Kumar et al. (2006) had mapped the location of up- and 
downstream regions critical for efficient cell-specific FSHB gene expression to 
–350 bp of basal promoter region and +3142 bp following translational stop 
codon in exon 3 (+6060 bp from the transcription start-site (TSS). Phylogenetic 
analysis demonstrated regions of highly conserved sequences corresponding to 
these locations (Figure 4).  
In the current study, in silico analysis has been performed to search the 
putative regulatory genetic elements/polymorphisms located within 3’- and 5’-
untraslated regions that may co-segregate with FSHB core variants shown to be 
under balancing selection.  
 
3.2.1.1 Variation pattern and potential regulatory units in conserved  
3’-flanking region of FSHB gene (unpublished results) 
A potential cis-acting gene regulatory unit, 296 bp long transposable element 
AluSg, spanning the region from +5771 bp to +6066 bp relative to the FSHB 
TSS was predicted within FSHB 3’-flanking region (Figure 8A) (RepeatMasker 
software, http://www.repeatmasker.org). Search for putative transcription factor 
binding sites resulted in identifying of Estrogen Response Element (ERE; from 
identified 
not 
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+5848 to +5864 relative to TSS) within the transposable element AluSg (Figure 
8A). The identified ERE is putative binding-site for estrogen receptor and may 
be involved in modulating of the expression of the FSHB gene (MatInspector 
7.4.3 software, http://www.genomatix.de/).  
 
 
 
 
Figure 8. Localization of (A) downstream (3’-region) and (C) upstream (5’-region) 
putative regulatory areas within the human FSHB genomic region ( ). Negative and 
positive numbers refer to positions relative to the transcriptional start-site, which is 
indicated by the arrow above exon 1. Untranslated and translated parts of exons (1, 2 
and 3) are indicated by white and grey rectangles, respectively. 
(A) Re-sequenced part of 3’-region of the FSHB gene. Identified polymorphic 
positions are marked with red circle-headed bars. The location of AluSg, transposable 
element found in forward orientation, was identified using RepeatMasker 
(http://www.repeatmasker.org) and marked with red horizontal line. The location of 
putative cis-acting regulatory element (Estrogen Response Element, ERE) within AluSg 
is shown and denoted by black arrow. 
(B) Structure of the FSHB gene. Coding exons are indicated by boxes and translated 
sequence is denoted by grey area. 
(C) A comparative alignment of the conserved 5’-upstream sequence element (from 
–212 to –197) shown to act as Progesterone Response Element (PRE) in ovine Fshb 
promoter (Webster et al. 1995). The sequences of corresponding promoter regions of 
five additional species including domestic sheep (Ovis aries, AH003774.1), rhesus 
monkey (Macaca mulatta, NC_007871.1), dog (Canis lupus familiaris, NC_006603.2), 
and mouse (Mus musculus, NC_000068.6) were downloaded from NCBI GenBank and 
used in the ClustalW multiple sequence alignment program (http://www.ebi.ac.uk/ 
Tools/msa/clustalw2/). Bases that differ from the human sequence are shown. The 
location of PRE and human polymorphic position -211G/T are marked on the alignment 
with red horizontal arrow and red vertical box, respectively. 
B
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In order to screen the variation within the FSHB conserved 3’-flanking genomic 
sequence area, 3480 bp of 3’-flanking region of FSHB gene (from +3658 to 
+7138 bp relative to TSS) was re-sequenced in nine Estonian, six Korean and 
three Utah Mormon/CEU individuals randomly chosen from samples described 
in Table 4. 
Within re-sequenced region, three single nucleotide substitutions (rs560078, 
rs626869, rs615577) and two deletion/insertion polymorphisms (rs10707736, 
rs11338941) were identified (Figure 8A). Deletion/insertion variants localized 
within 16 bp long poly(A) sequence and were omitted from the further analysis 
because genotypes were not reliably assigned. 
Significant allelic associations among SNPs throughout the FSHB 3’-
flanking re-sequenced area were found (Figure 9). Moreover, when five 
polymorphisms from the entire FSHB gene (rs550312, rs611246, rs609896, 
rs594982, rs6169) and 3’-flanking region polymorphisms (rs560078, rs626869, 
rs615577) were analyzed for LD using the measure r2, the block of complete LD 
was found (Figure 9). 
As none of the identified polymorphisms within FSHB gene 3’-flanking re-
sequenced area have been found to localise within putative transcription factor 
binding sites, this gene region was not analysed further. 
 
 
 
 
Figure 9. Linkage disequlibrium (LD) structure of the analyzed FSHB genomic locus 
spanning the FSHB gene (~3 kb) and 3’-downstream region (~3.5 kb) in nine Estonian, 
six Korean and three unrelated Utah Mormon/CEU individuals. The physical 
localization for analysed SNPs on the FSHB gene is shown. Red squares indicate that 
pairwise LD correlation coefficient, r2, between all SNPs in the FSHB gene region is 
1.00 meaning full LD. LD was estimated and LD plot was drawn with Haploview 
software (Barrett et al. 2005; http://www.broadinstitute.org/scientific-community/ 
science/programs/medical-and-population-genetics/haploview/haploview/). 
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3.2.2 Screening and variation pattern in FSHB gene evolutionary 
conserved promoter region 
According to Kumar et al. (2006) and other studies on FSHB gene expression 
regulation, the proximal part of the gene promoter region containing multiple 
putative transcription factor binding sites is essential for efficient gene expres-
sion (Figure 4, Figure 6). In order to identify potential gene polymorphisms 
altering gene expression, screening of the human genome SNP database 
(dbSNP, NCBI, http://www.ncbi.nlm.nih.gov/) and manual inspection of 
previously reported regulatory sequence motifs within 350 bp upstream from 
transcriptional start-site were performed. 
The database and literature search have resulted in the identification of an 
uncharacterised SNP (rs10835638, G/T) 211 bp upstream from the FSHB 
mRNA start-site (GenBank, NM_001018080.1). This SNP is located within a 
region which is conserved across mammals (Figure 8C) and is shown to act as 
Progesterone Response Element (PRE) capable of binding progesterone 
receptor (PR), thereby, regulating gene transcription. Moreover, functional 
studies conducted with ovine Fshb 5’-flanking region have shown that con-
served G nucleotide at position –211 is one of critical positions for proper 
functioning of progesterone response element and efficient FSHB gene expres-
sion (Webster et al. 1995). Functional study on the human FSHB promoter 
activity showed that T allele in the FSHB gene promoter position –211 results in 
approximately 50% reduction in FSHB gene mRNA expression level (Hoogen-
doorn et al. 2003). Since concentration of the functional heterodimeric FSH has 
shown to correlate highly with intra-pituitary levels of FSHB mRNA transcripts 
(McNeilly et al. 2003), the position –211 G/T in FSHB promoter was targeted 
for further analyses of the association with human reproductive traits. 
  
3.2.2.1 FSHB gene position -211 G/T alternative allele T is enriched in 
patients with male factor infertility 
In order to study the effect of single nucleotide polymorphism at the FSHB gene 
position –211 G/T on male testicular and hormonal parameters, the position was 
genotyped for the cohorts of young men (Estonia, n=554; Latvia, n=277; 
Lithuania, n=223) and Estonian patients with male factor infertility (n=1029) 
(Table 10). Genotyping procedure is described in Ref. III. 
Compared to Estonian young male cohort patients diagnosed with infertility 
exhibited a significant excess of both rs10835638 alternative allele T-homo-
zygotes (1.1% vrs 2.4%) as well as GT-heterozygotes (22.4% vrs 25.1%) 
(p<0.05, Table 11). The difference in genotype frequencies remained border-
line significant when patients with primary causes of infertility were excluded 
and only patients with idiopathic infertility were analysed (p<0.1). 
Additionally, FSHB gene position –211 was genotyped in Latvian (n=277) 
and Lithuanian (n=223) cohorts of young men (Table 10). The distribution of 
500 studied Latvian and Lithuanian individuals, on the basis of the FSHB gene 
promoter position –211, was 373 in GG (74.6%), 119 in GT (23.8%) and 8 
(1.6%) in TT groups. 
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3.2.2.2 FSHB gene position -211 G/T is associated with male serum FSH 
level 
In order to find whether the FSHB gene promoter polymorphism -211 G/T is 
associated with male serum FSH level, marker-trait analysis by multiple linear 
regression with adjustment for appropriate confounders was performed. 
Multiple linear regression analysis revealed a strong association of rs10835638 
alleles with serum FSH level both in the cohort of young Estonian men 
(GG>GT>TT, median FSH 2.98>2.46>2.06 IU/L, p<0.005; Table 1 in Ref. III) 
and in the cohort of male infertility patients (GG>GT>TT, median FSH 
6.8>5.4>3.5 IU/L, p<<0.001; Table 2, 3 in Ref. IV). In both Estonian cohorts, 
subjects with TT and GT genotypes exhibited 30–50% and 16–35% lower 
serum FSH levels, respectively, than those in GG homozygotes (Table 1 in Ref. 
III; Table 2 in Ref. IV). The association of the SNP alleles with male serum 
FSH level remained significant when patients with causal factors for infertility 
were omitted from the analysis (p<<0.001; GG>GT>TT, 6.4>5.3>3.3 IU/L, 
Figure 10A).  
Consistent with the results obtained from the analyses of both Estonian 
young men and Estonian infertility patients, in Baltic cohort of young men, the 
minor allele T of the rs10835638 was significantly associated with serum FSH 
level (p<<0.001). TT-homozygotes (median FSH 1.8 UI/L) had approximately 
10% and 22% lower FSH levels than GT-heterozygotes (2.0 IU/L) and GG-
homozygotes (2.3 IU/L), respectively (Table 12, Figure 10A; Table 2 in Ref. 
V). 
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3.2.2.3 FSHB gene position -211 G/T is associated with other male 
quantitative reproductive parameters 
To characterize the detailed influence of FSHB promoter variants on male 
reproductive health, association of the FSHB gene position -211 alleles with 
several additional male hormonal (inhibin B, LH, total testosterone, estradiol) 
and testicular parameters (total testes volume, sperm concentration, total sperm 
count, semen volume, sperm forward (A+B) motility, sperm morphology) in 
Baltic cohort of young men (n=1054) and in Estonian cohort of idiopathic 
infertility patients (n=1029) was assessed (multiple linear regression with 
additive and recessive models with adjustment for confounders) (Table 12). 
In Baltic cohort of young men, the dosage of the T-allele was significantly 
associated with reduced serum inhibin B level (linear regression additive model, 
p=2.16x10–3, Table 12). Inhibin B levels in TT-homozygotes were approxi-
mately 20% and 5% lower than those in GG-homozygotes and GT-hetero-
zygotes, respectively (GG>GT>GG, adjusted median 180>172>142 pg/mL; 
Figure 10B). Most probably due to restriction that inhibin B measurement data 
were available for 294 individuals only, in Estonian male patients diagnosed 
with idiopathic infertility, the association didn’t reach the level of statistical 
significance. However, compared to GG-homozygotes, TT-homozygotes and 
GT-heterozygotes exhibited 28% and 7% lower inhibin B levels, respectively 
(median inhibin B pg/mL, GG>GT>TT, 80.6>75.2>58.2; Figure 10B; Table 3 
in Ref. IV). 
Additionally, serum LH and total testosterone levels were significantly 
associated with FSHB rs10835638 carrier status in Baltic cohort of young men 
(LH, recessive linear regression, p=2.25x10–2; total testosterone, additive linear 
regression, p=9.30x10–3) (Table 12). Compared to GG- and GT-genotype 
carriers, the TT-subjects had increase in serum LH (5.0 IU/L vrs. 4.0 IU/L), but 
decrease in total testosterone level (GG>GT>TT, 25>24>23 nmol/L) (Figure 
10C, D). Neither serum LH nor total testosterone was affected by the carrier 
status of rs10835638 in idiopathic infertility patients (Figure 10C, D; Table 3 in 
Ref. IV). The lack of the association with LH and testosterone may be explained 
in two ways: (i) in infertile males, reproductive physiology and hormonal 
feedback mechanisms are disturbed in general, (ii) infertile patients exhibit high 
range and non-normal distribution of hormonal measurements. 
Estradiol was slightly increased in TT-homozygotes compared to GG- and 
GT-individuals in either Baltic cohort of young men or Estonian idiopathic 
infertility patients (Baltic cohort of young men, GG~GT<TT, adjusted median 
78~76<84 pmol/L; Estonian infertility patients, GG~GT<TT, median 88~87<98 
pmol/L) (Table 12). 
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Figure 10. Box-and-whisker diagrams for the distribution of hormonal parameters: (a) 
serum FSH, (b) inhibin B, (c) serum LH, (d) total testosterone; and testicular and semen 
parameters: (e) total testes volume, (f) sperm concentration in the Baltic young men 
cohort (n=1054) (left panel) and Estonian male patients diagnosed with idiopathic 
infertility (n=750) (right panel). Individuals are subgrouped according to their FSHB 
promoter SNP rs10835638 genotype (Baltic young men cohort, GG/GT/TT, 
796/244/14; Estonian male infertility patients, GG/GT/TT, 545/186/19). The boxes 
represent the 25th and 75th percentiles; the whiskers cover the 5th-95th percentiles of 
the data. Circles represent the outlier values. The median is either the value inside the 
box or the red line that bisects the boxes. For Baltic young men cohort, the confounder 
adjusted median values are shown (detailed description in Ref. V, Supplementary Text).  
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The effect of FSHB gene rs10835638 alleles on male testicular parameters 
was tested. The position rs10835638 TT-homozygotes demonstrated lower total 
testes volume in Baltic young men and Estonian idiopathic infertility patients 
(Baltic cohort, recessive linear regression, p=1.47x10–2; Estonian infertility 
patients, p=9.26x10–2). When compared to GG- and GT-genotype carriers, TT-
homozygotes had 15–20% lower total testes volume than GG-homozygotes and 
GT-heterozygotes (Figure 10E, Table 2 in Ref. V; Table 3 in Ref. IV). More-
over, in Baltic cohort, sperm concentration was reduced in TT-individuals 
(adjusted median, 42 mln/mL) compared to GG- (63 mln/mL) and GT-
individuals (63 mln/mL) (Figure 10F; Table 2 in Ref. V). Most probably due to 
high range of sperm concentration measurements and inclusion of cases with 
azoospermia, no significant association has been revealed in patients diagnosed 
with infertility (Figure 10E; Table 3 in Ref. IV). 
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4. DISCUSSION 
4.1 The fine-scale variation of the FSHB gene and 
signatures of balancing selection 
Genes that affect fertility and hormonal system are expected to be subject to 
strong selection owing to their direct effects on reproduction-related traits 
(Matzuk and Lamb 2008). Consistent with the essential function of the FSHB 
gene in reproduction, stringent purifying selection acts towards the changes in 
the translated region of the gene due to their deleterious effect. Confirming pre-
vious reports by Liao et al. 1999 and Lamminen et al. 2005, full re-sequencing 
of the FSHB gene in 96 individuals representing Europe (Estonia), Africa 
(Mandenka), and Asia (Han Chinese) did not uncover any non-synonymous 
changes. The majority of the FSHB SNPs were represented by common 
polymorphisms having worldwide occurrence. In contrast to the evolutionarily 
preserved FSHB gene, the highly diverse LHB/CGB gene cluster coding for 
luteinizing and chorionic hormone β-subunits was described as a region with 
dynamic genetic evolution (Hallast et al. 2005). Despite the FSHB gene and 
LHB/CGB cluster belong to the family of gonadotropin β-subunit genes, the 
FSHB gene exhibits approximately six-fold lower nucleotide diversity and 
stable genomic structure compared to the LHB/CGB gene locus exhibiting high 
number of population-specific variants (Hallast et al. 2005, Henke and Gromoll 
2008). In LHB/CGB region, high level gene variation and active genome dyna-
mics possibly generating unfavourable variants are compensated by multiple 
gene copies guarantying the required gene transcription dosage (Ref. I). 
The results in Ref. II showed that FSHB exhibits strong linkage disequi-
librium (LD) throughout the entire gene region and 3’-flanking area; and 
respective genomic region is presented by a pair of ‘yin yang’ core haplotypes 
spread worldwidely. The FSHB core variants are composed of at least eight 
consecutive SNPs that are inherited together (Figure 7, 9). ‘Yin yang’ haplo-
types found in high frequencies among human populations have been suggested 
to enrich either (i) by chance under a neutral evolutionary model (Zhang et al. 
2003), (ii) due to the events in population history such as admixture between 
two founder populations (Prugnolle et al. 2005, Curtis and Vine 2010), or (iii) 
due to the influence of balancing selection (Bamshad and Wooding 2003). In 
the case of the FSHB gene, the nearly equal allele frequencies of SNPs and the 
results of neutrality tests refuted the hypothesis on neutral evolution. Firstly, the 
demographic history of the entire human population, characterized by a series 
of population bottlenecks, may have shaped modern human genetic diversity of 
the FSHB gene leading to the enrichment of the second core haplotype in 
populations with European descent (Harpending and Rogers 2000, Amos and 
Hoffman 2010). However, all the studied populations share the two FSHB gene 
core haplotypes and demonstrate similar results for neutrality tests. Thus, the 
influence of the ancient balancing selection maintaining the simultaneous 
enrichment of two core haplotypes is more obvious. Interestingly, all examined 
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great apes species were homozygous for the gene variant more similar to the 
FSHB second core haplotype pinpointing the ancestral FSHB variant. 
The balancing selection can arise when variation in phenotypic con-
sequences, upon which it can act, is present (Bamshad and Wooding 2003, 
Crespi 2010). A classic example of balancing selection is found in the 5’ cis-
regulatory region of the CCR5 gene, the co-receptor for HIV-1. At this locus, 
balancing selection created two major advantageous haplotype groups to 
maintain the defence against pathogens (Bamshad et al. 2002). Although 
relatively few single-gene studies for regions involved in fertility and re-
production have been performed so far, loci associated with medically relevant 
fertility phenotypes have been identified to be under the influence of balancing 
selection (reviewed in Crespi 2011). Similarly to the FSHB gene, the haplotype 
structure of CGB8 gene promoter has been shown to be consistent with the 
scenario of balancing selection that might have triggered the enrichment of two 
divergent clusters of haplotypes possibly associated with different pregnancy 
success (Rull et al. 2008). As the FSHB gene haplotypes are composed of silent 
or non-coding polymorphisms, neither core variant affects the composition of 
the FSHB protein directly. Thus, balancing selection may be operating towards 
an upstream or downstream causative variant in tight linkage disequilibrium 
with the FSHB gene haplotypes. 
 
 
4.2. The dosage of the follicle-stimulating hormone  
affects male reproductive parameters 
4.2.1. Application of evolutionary genetics in studying gene 
functional domains 
Phylogenetic analysis of mammalian and nonmammalian genomes has fre-
quently been used to identify selectively constrained and functionally important 
sequences (Batzoglou et al. 2000, Dermitzakis et al. 2002, DeSilva et al. 2002, 
Woolfe et al. 2005). Comparison of the coding regions in human and mouse has 
revealed that exons in H. sapiens and M. musculus exhibit 85% identity at the 
nucleotide level. In contrast, introns tend to show lower similarity, approxi-
mately 35% (Makałowski et al. 1996, Batzoglou et al. 2000). In addition to 
protein coding regions, subsets of non-genic sequences that are not functionally 
transcribed have also been demonstrated to exhibit high conservation across 
vertebrate genomes. Evolutionary conservation has become widely used as a 
start-point for identifying putative genomic regions contributing to the regu-
lation of gene expression (Dermitzakis et al. 2005, Drake et al. 2006, King et al. 
2007). Initially, functionally conserved non-genic DNA sequences (CNGs) 
were defined as regions that are ≥70% identical over at least 100 bp of un-
gapped alignment of mouse and human sequences (Duret et al. 1993, 
Dermitzakis et al. 2002). Although the amount of sequence fulfilling this strict 
criterion is only about 1% of the human genome (Dermitzakis et al. 2005), 
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studies adopted this definition of CNGs have identified several biologically 
relevant non-coding loci associated with disease phenotypes, such as Gaucher 
disease (Blech-Hermoni et al. 2010) and cleft lip (Rahimov et al. 2008). 
When the generation of alignment between species is not feasible, motif-
finding methods with subsequent experimental annotation have also been used 
to isolate functional sequences, mostly in detection of transcription factor-
binding sites (TFBSs) (Roth et al 1998, So et al. 2007, Gaffney et al. 2008). 
Combination of two approaches–evolutionary sequence conservation and 
biological relevance of the locus–revealed functional regulatory loci in the 
immune response gene, interleukin-6 (IL-6). Two polymorphisms in the IL-6 
gene promoter located in close proximity to glucocorticoid response element 
(GRE) were shown to modify the expression of the gene and affect various 
downstream biochemical markers and disease phenotypes (Ferrari et al. 2003, 
Morgan et al. 2006). The conservation of the entire Fshb/FSHB gene genomic 
sequence along with upstream and downstream flanking sequences across the 
vertebrate lineage is a signature of strong natural selection acting towards both 
coding and non-coding regions of the gene (Figure 4, Kumar et al. 2006). The 
changes within the protein-coding region of the FSHB gene are selected against 
due to their drastic effect on reproduction. The proximal promoter region up to 
‒350 bp relatively to the FSHB transcription start-site was shown to harbour 
multiple conserved TFBSs, cis-acting regulatory elements, capable of altering 
the expression of the FSHB gene (Figure 6, Bernard et al. 2010, Melamed 
2010). The binding of the progesterone-progesterone receptor complex to the 
PRE sequence element (corresponds to ‒197…‒212 bp from the human FSHB 
TSS) in the ovine Fshb gene promoter was shown to be capable of enhancing 
the gene expression (Webster et al. 1995). The position –211 G/T was shown to 
be critical in proper functioning of the PRE motif (Webster et al. 1995, 
Hoogendoorn et al. 2003), thus, representing a reasonable target locus for a 
study of the fitness effects of nucleotide substitutions within regulatory non-
coding DNA. 
 
 
4.2.2. The FSHB position –211 G/T: the association with  
serum FSH level and testes volume 
This study has shown strong evidence for the association between the FSHB 
position –211 G/T and serum FSH level in the Baltic cohort of young men (Ref. 
V) and in the Estonian patients diagnosed with infertility (Ref. IV). Among –
211 G/T genotype carriers, the declining gradient of the serum FSH 
measurements was observed (GG>GT>TT). The serum FSH level gradient 
among the FSHB –211 G/T genotype carriers is consistent with the results of a 
functional study on polymorphic proximal promoters of 170 human genes that 
revealed that alternative allele in the FSHB position ‒211 G/T results in the 46–
50% reduction of the FSHB gene expression level (Hoodendoorn et al. 2003).  
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Considerable efforts have been undertaken to understand the relative impor-
tance of follicle-stimulating hormone and luteinizing hormone/testosterone for 
full male fertility. It is generally assumed that FSH plays essential role in 
regulation of quantitatively and qualitatively normal spermatogenesis in male 
mammals (Nieschlag et al. 1999, Plant and Marshall 2001, Weinbauer et al. 
2010). Mice lacking FSH (FSHβKO) or FSH receptor (FSHRKO) showed that 
FSH is required for normal development of Sertoli cell and germ cell numbers 
as well as entry of spermatogonia into meiosis (Kumar et al. 1997, Abel et al. 
2000, Krishnamurthy et al. 2000, Abel et al. 2008). 
The sole target for the dimeric FSH molecule in male testes is Sertoli cell 
possessing cell membrane FSH receptors (FSHR). It is possible to distinguish 
roughly three time points, or developmental periods, of irreplaceable FSH 
action. 
First, fetal FSH is the stimulator of immature Sertoli cells proliferation 
during male fetal and especially early neonatal development (Hansson et al. 
1975, Singh and Handelsman 1996, Sharpe 2003, Baines et al. 2008, O’Shaugh-
nessy et al. 2009). The exact role of the FSH during fetal development conti-
nues to be debated, since Sertoli cell number was shown to be normal during 
embryonal development in gonadotropin-releasing hormone deficient mice 
(hpg) (Baker and O’Shaughnessy 2001) and follicle-stimulating hormone re-
ceptor knockout mice (FSHRKO) (Johnston et al. 2004). However, in anen-
cephalic human fetuses that exhibited the absence of hypothalamus and 
pituitary as well as in hypophysectomised rhesus monkey fetuses, the marked 
reduction in testes size was observed (Baker and Scrimgeour 1980, Gulyas et al. 
1977). Suppression of the neonatal FSH concentration in rats reduces the final 
number of Sertoli cells by about 40% (Atanassova et al. 1999, Sharpe 1999). 
After birth, Sertoli cells expressing androgen receptors (ARs) also mediate 
androgen (testosterone) driven action required for meiotic and postmeiotic germ 
cell development (De Gendt et al. 2004, Tan et al. 2005, O’Shaughnessy et al. 
2010a). 
Secondly, the synergic action of the FSH and Leydig cells-produced testoste-
rone is needed for the radical switch from an immature, proliferative state to a 
mature, non-proliferative state Sertoli cells during pubertal period (Tan et al. 
2005, Willems et al. 2010). The functional maturation of Sertoli cells includes 
also the establishment of the blood-testis barrier (BTB), which in turn is 
connected with the process of formation of tight junctions between Sertoli cells 
during puberty. It was established that gonadotropin suppression results in 
disorganisation of tight junctions’ proteins and loss of BTB function in rodent 
testis and the effect is reversible by FSH replacement (Tarulli et al. 2008, 
McCabe et al. 2010, Chui et al. 2010). Since each individual mature Sertoli cell 
is able to support a defined number of sperm (10 germ cells or 1.5 spermatozoa, 
Zhengwei et al. 1998), the finite size of Sertoli cells population determined 
during early stages of reproductive development–fetal, neonatal, and pubertal 
periods–is closely correlated to the capacity of the adult testes for sperm 
production. Consistently, Johnson et al. (1984) showed positive linear 
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correlation between number of Sertoli cells in adult human testis and dayly 
sperm production. 
And thirdly, in adult male, FSH is involved in complex paracrine and 
endocrine regulatory control pathways, hypothalamic-pituitary-gonadal axis 
(Figure 3, Sharpe et al. 2003, Weinbauer et al. 2010). 
Consistently with the role that plays FSH in the proliferation and functional 
maturation of Sertoli cells in the testes, the current study (Ref. III–V) 
demonstrated that homozygotes TT for FSHB gene promoter position –211 
(rs10835638) having the genetically determined lowest levels of serum FSH 
display an approximately 20% reduction in testes volume both in the Baltic 
cohort of young men and in Estonian cohort of males diagnosed with idiopathic 
infertility. Thus, the alternative allele T in the regulatory position within FSHB 
promoter causing lower production of FSH is associated with reduction in testes 
volume, one of the most important parameters for estimating male reproductive 
capacity (Luetjens et al. 2005, Sakamoto et al. 2008, Nieschlag and Behre 
2010). The evidence of the association with testes volume is consistent with the 
reduced testes size in the FSHβ-deficient mice and human males (Kumar et al. 
1997, Phillip et al. 1998, Themmen and Huhtaniemi 2000). The testes volume 
in GT-heterozygotes was not affected, most probably due to possible involve-
ment of compensatory mechanisms to maintain physiologically normal repro-
ductive capacity. 
 
 
4.2.3. The association with other secondary male reproductive 
parameters: long-term and short-term effects of reduced FSH 
production 
An independent case report by Mantovani et al. (2003) has described a young 
male patient with normal virilization, azoospermia and isolated FSH-deficiency, 
who was homozygous for the T-allele of the FSHB –211 G/T polymorphism. 
This clinical case allows suggesting a hypothesis of possible contribution of this 
polymorphism to male infertility phenotype. The current study showed that the 
genetically inherited constituitevly diminished production of FSH affects a 
broad range of male reproductive parameters including sperm concentration and 
levels of inhibin B, testosterone and LH.  
The declining gradient (GG>GT>TT) of inhibin B level and sperm 
concentration among FSHB promoter rs10835638 genotype groups in Baltic 
cohort of young men was observed. Inhibin B is a unique Sertoli-germ cells 
joint product that is secreted into male circulation upon the FSH-stimulation 
(Ramaswamy and Plant 2001, Weinbauer et al. 2010). Since serum FSH levels 
are not only determined by the testis but also influenced by hypothalamic 
function, inhibin B may offer a useful and direct serum marker describing 
gonadal functions (Anawalt et al. 1996, Meachem et al. 2001, Kumanov et al. 
2006, Simoni and Nieschlag 2010). 
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The reduced levels of the inhibin B and sperm concentration in T-allele 
carriers may refer to the short-term effect of lower FSH secretion. Additionally, 
FSH-understimulated processes during male reproductive development may 
result in long-term effects including impaired functioning of the testes Sertoli 
cells (Sharpe et al. 2003). Quantitatively and qualitatively normal spermato-
genesis is depending upon testis spermatogenic capacity built up during repro-
ductive development as well as immediate effect of endocrine regulation (Wein-
bauer et al. 2010). In adult hpg mice, spermatogenesis was severely disrupted, 
and FSH treatment increased the germ cell number as well as spermatogonial 
and spermatocyte numbers by three- to fourfold (O’Shaughnessy et al. 2010b). 
Recently, it was established that in normal adult males FSH plays a key role in 
the regulation of apoptotic pathways during spermatogenesis supporting 
survival of spermatogonia and sperm release (spermiation) (Ruwanpura et al. 
2008, 2010).  
Additionally to the direct effect of FSH on the actions of Sertoli cells expres-
sing FSH receptor, FSH has been shown to indirectly affect also testosterone-
producing Leydig cell function. Although the gonadotropin-independent role for 
FSH receptors in FSHβ-deficient mice have been suggested (Baker et al. 2003), 
FSH-stimulated Sertoli cells produce various factors (e.g. proteins, cytokines, 
steroids, growth factors, modulators of cell division) that contribute to the 
induction of adult Leydig cell differentiation and functional maturation 
(O’Shaughnessy et al. 1992, Matikainen et al. 1994, Sriraman and Jagannadha 
Rao 2004, O’Shaughnessy et al. 2009 and references therein). Thus, it is intri-
guing that among Baltic young men, homozygotes for the minor allele had 
higher serum LH but lower testosterone level when compared to heterozygotes 
or homozygotes for the major allele. Reduced testosterone level in a com-
bination with elevated serum LH level is used as sensitive marker of the im-
paired functioning of Leydig cells (Giagulli et al. 1988, Brennemann et al. 
1997, Holm et al. 2003). The alternative T allele in FSHB promoter position –
211 results in a lower level of mRNA expression and functional FSH formation 
during reproductive development what, in turn, is a cause of diminished activity 
of adult Leydig cells. 
 
 
4.3. Implications and further development of the study 
The carriers of the T-allele of the FSHB –211 G/T SNP represent a natural 
model for documenting short-term and long-term downstream effects of 
insufficient FSH action due to genetically inherited constitutively reduced 
hormone levels. Diminished production of the functional FSH results in changes 
in various complex networks of hormonal interactions regulating human fertility 
potential. The results of the current study showed the enrichment of the FSHB 
gene alternative allele T among Estonian cohort of infertility patients compared 
to the cohort of young men. This observation provides evidence for the possible 
contribution of this position to the complex phenotype of male infertility. 
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Impaired spermatogenesis is one of the first symptoms of testicular dysgenesis 
syndrome (TDS) (Skakkebaek et al. 2001) including also such traits as 
cryptorchidism, hypospadias, testicular germ cell cancer. Although TDS is most 
likely caused by a combination of environmental and life-style factors (Sharpe 
2010), the genetic predisposition to this syndrome cannot be ruled out (Aschim 
et al. 2005). Additional studies are needed to be conducted to examine the 
detailed effect of the FSHB gene promoter position –211 G/T on various 
developmental issues in male. 
It has been demonstrated that highly purified or recombinant FSH is an 
appropriate and valid treatment of oligozoospermic patients. However, only 
selected patient react positively on FSH therapy. FSH can improve seminal 
parameters in patients with FSH plasma levels in the normal range and testes 
tissue structure characterized by hypospermatogenesis without germ cell 
maturation disturbances (Baccetti et al. 2004, Paradisi et al. 2006, Foresta et al. 
2000, 2008; Nieschlag and Kamischke 2010, Palomba et al. 2011). Deter-
mination of the genotype of the FSHB promoter polymorphism would allow the 
identification of the patients, whose primary cause of the infertility problems 
may be too low FSH production. Further investigations into the efficacy of FSH 
treatment on the basis of genetic polymorphisms are required to identify further 
parameters that are able to predict the seminal response to FSH treatment. 
 In the current thesis, a pilot-study for the association between the FSHB two 
divergent core haplotypes and female fertility revealed enrichment of the FSHB 
second core variant among ‘short time to pregnancy’ women (STP-sample) 
(Table 9; Ref. II). Noteworthy, the inclusion criterion for the Utah Mormon 
families’ enrollment was high number of offspring, at least eight children 
(Dausset et al. 1990). The functional consequence of the FSHB core haplotypes 
remains to be elucidated. In future studies, confounding impacts of different 
covariates relating both partners such as data on anthropometric characteristics 
(e.g. age, body mass index) and covariates relating to both partners (smoking 
status, current alcohol consumption, frequency of intercourse etc.) are required 
(Joffe et al. 2005, Wise et al. 2011). 
Time to pregnancy is a functional measure of biologic fertility depending on 
female ovary folliculogenic capacity and interplay between various molecular 
agents exerting their effects during fetal, pubertal and adult life periods. The 
adequate concentration of the FSH during female reproductive development 
may preprogram certain measures of women fertility potential in adulthood 
such as age at menarche, menstrual cycle length, time to pregnancy, ovarian 
aging, and age at natural menopause as well as response in IVF. Future research 
focusing on the effect of the FSHB gene promoter polymorphism –211 G/T on 
FSH level and female fertility parameters would provide new insights into the 
role and consequeces of differential ovarian stimulation by FSH. 
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SUMMARY AND CONCLUSIONS 
The results of this thesis can be summarized as follows: 
1. Follicle-stimulating hormone β-subunit gene (FSHB) coding for FSH β-
subunit protein exhibits absence of common non-synonymous changes and 
excess of high frequency non-coding polymorphisms in six studied human 
populations (Estonians, Mandenkalu, Han Chinese, Koreans, Czechs, unrelated 
Utah Mormons/CEU). The respective genomic region is characterized by strong 
pairwise linkage disequilibrium throughout the entire FSHB gene sequence. 
Low genetic diversity and strong LD extends to the 3’-flanking region of the 
FSHB gene. 
2. The human FSHB gene is represented by two core genetic variants 
(haplotype 1 and haplotype 2) spread worldwidely with population-specific 
frequencies, whereas the FSHB gene haplotype 2 is found to be enriched among 
populations of European origin (Estonians, Czechs and unrelated Utah 
Mormons/CEU). Core haplotypes differing in each polymorphic position (‘yin-
yang’ haplotypes) and excess of polymorphisms with intermediate allele 
frequencies may indicate that the FSHB gene is under the influence of balancing 
selection.  
3. Comparison of the translated parts of the FSHB gene in human and great 
apes (chimpanzee, gorilla, and orangutan) has revealed eleven and three 
nucleotide and amino acid differences, respectively. All the studied great apes 
are homozygous for the FSHB gene haplotype similar to the human FSHB gene 
second frequent variant (haplotype 2). 
4. The results of a genetic association pilot-study on possible effect of the 
FSHB gene variants on female reproductive health has indicated significant 
difference in the distribution of the homozygotes for the haplotype 2 between 
random population-based cohort of Estonian women and Estonian females 
conceived naturally within three months after stopping contraception. The latter 
sample demonstrated the enrichment of the FSHB haplotype 2. Since the FSHB 
core variants consist of non-coding polymorphisms, genetic variants that 
distinguish the FSHB two core haplotypes may co-segregate with functional 
regulatory variants either upstream or downstream of the FSHB gene possibly 
contributing to the gene expression regulation. 
5. In silico screening of the immediate 5’-flanking promoter region (‒350 bp 
relative to transcription start-site) of the FSHB gene has resulted in the 
identification of previously uncharacterized putative regulatory polymorphic 
position ‒211 G/T (rs10835638). This SNP is located within Progesterone 
Response Element (PRE) capable of modulating FSHB gene expression. 
6. When the allele and genotype frequencies of ‒211 G/T SNP were 
compared between the Baltic cohort of young men (Estonians, Latvians, 
Lithuanians; n=1054) and Estonian male patients diagnosed with infertility 
(n=1029), the frequency of the alternative allele T was higher in the latter. Thus, 
the FSHB promoter position ‒211 G/T may contribute to male infertility 
phenotype. 
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7. The quantitative genetic association studies on possible effects of the 
FSHB gene ‒211 G/T SNP allelic status on male reproductive parameters have 
provided strong evidence of significant association between ‒211 G/T carrier 
status and serum FSH level. Both in the Baltic cohort of young men and in the 
male patients diagnosed with idiopathic infertility, carriers of GT- and TT-
genotypes exhibited 16–35% and 30–50% lower serum FSH levels, 
respectively, when compared to GG-genotype carriers. 
8. Additionally, significant secondary associations between the FSHB 
promoter position and other male testicular and hormonal parameters including 
inhibin B, total testosterone, serum LH level, sperm concentration, and testes 
volume were identified. Carriers of the TT-genotype had approximately 20% 
lower total testicular volume when compared to GG- and GT- genotype carriers. 
These associations refer to the possible short-term and long-term downstream 
pleiotropic effects of lower serum FSH levels in men. Genetically determined 
lower FSH level during male embryonal, early natal, and pubertal development 
may affect different downstream reproductive parameters and contribute to the 
regulation of male reproductive potential. 
 
Main outcome of the study: 
The current study identified the first FSHB gene polymorphism that determines 
the level of male serum FSH and recapitulated the essential role of FSH in male 
reproductive processes.  
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SUMMARY IN ESTONIAN 
Folliikuleid-stimuleeriva hormooni beeta-alaühikut kodeeriva geeni 
(FSHB) järjestuse varieeruvus ja selle seos reproduktiivtervisega 
Folliikuleid stimuleeriv hormoon ehk follitropiin (FSH), luteiniseeriv hormoon 
ehk lutropiin (LH) ja kooriongonadotropiin (hCG) on glükoproteiinsed gonado-
tropiinid, mis reguleerivad mõlema sugupoole sugurakkude teket ja küpsemist 
ning suguhormoonide tootmist. Igale gonadotropiinile on evolutsiooni käigus 
kinnistunud konservatiivne ning ajaliselt ja koeliselt spetsialiseerinud funkt-
sioon. FSH ja LH tootmist ajuripatsi (hüpofüüsi) eessagara rakkudes reguleerib 
peamiselt vabastajahormoon (Gonadotopin Releasing Hormone, GnRH), mis 
eritub hüpotaalamuses. Suurel määral toimub regulatsioon tagasiside mehha-
nismil põhineva hüpotaalamuse, ajuripatsi ja gonaadide süsteemis hormoonide 
(peamiselt östrogeenid, testosteroon, progesteroon) abil, lisaks mõjutavad FSH 
ja LH tootmist ka muud parakriinsed ja endokriinsed tegurid. FSH seondub 
munasarja granuloosa rakkude membraanis paiknevate retseptoritega ja stimu-
leerib naistel munasarja folliikulite arenemist, küpsemist ja östrogeenide toot-
mist. LH põhjustab küpse folliikuli ovulatsiooni ja stimuleerib kollaskeha teeka 
rakkudes androgeenide tootmist. Meestel on FSH signaalirada oluline munandi 
Sertoli rakkude paljunemisel ja küpsemisel loote-, vastsündinu- ja puber-
teedieas; täiskasvanueas on  FSH vajalik normaalseks spermatogeneesiks. LH 
tagab testosterooni tootmise munandi Leydigi rakkudes, mis on oluline nii 
spermatogeneesis kui ka suguorganite arengus. hCG toodavad platsenta 
süntsüütsiotrofoblasti rakud – seega hCG on lootelt pärinev rasedusspetsiifiline 
hormoon. HCG on vajalik viljastatud munaraku implantatsiooniks, immuun-
tolerantsi tekkeks ema ja loote vahel ning  raseduse normaalseks kuluks. 
Gonadotropiinide perekonna liikmed on heterodimeersed valgud, mis koos-
nevad kahest alaühikust. α-alaühik on kõikidel gonadotropiinidel identne, 
hormooni spetsiifilise toime ja retseptoriga seondumise määrab hormooni-
spetsiifiline β-alaühik. LH ja hCG β-alaühikuid kodeerivad geenid on väga 
kõrge DNA järjestuse sarnasusega ja paiknevad ühes geeniklastris19. kromo-
soomi pikas õlas (19q13). Geeniklastrisse kuulub üks LHB geen, mis kodeerib 
LH β-subühikut ning kuus CGB geeni, millest 4 kodeerivad hCG β-subühikut 
(CGB, CGB5,7, ja 8). FSH β-subühikut kodeerib üks FSHB geen, mis on ligi 
neli tuhat aluspaari pikk ja paikneb 11. kromosoomis. Võrdleva genoomika 
analüüsi põhjal ilmneb, et teatud FSHB geeni piirkonnad: valku kodeeriv 
piirkond ning geeniga vahetult piirnevad mittekodeerivad piirkonnad, on liigiti 
väga kõrge DNA järjestuse sarnasusega viidates mainitud piirkondade tähtsale 
funktsioonile. Inimestel on seni tuvastatud ainult viis aminohapet muutvat 
mutatsiooni (kokku üheksa indiviidi), mis kõik põhjustavad olulisi muutusi 
valgustruktuurisning seonduvad viljatusega nii meestel kui ka naistel. 
Vaatamata sellele, et FSH ja selle β-alaühikut kodeeriv geen FSHB on 
asendamatu reproduktsioonil, on seni vähe uuringuid, mis kirjeldavad FSHB 
geeni varieeruvust ja selle mõju inimese reproduktiivtervisele.  
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Doktoritöö kirjanduse ülevaade hõlmab gonadotropiinide evolutsiooni, 
molekulaarset struktuuri ja funktsioone. Järgmisena on tutvustatud gonadotro-
piinide alaühikuid kodeerivaid geene; FSH β-alaühikut kodeeriva geeni struk-
tuuri ja varieeruvust; ning geeni ekpressiooni ehk avaldumise regulatsiooni. 
 
Doktoritöö eksperimentaalses osas on püstitatud järgmised eesmärgid: 
(i)  iseloomustada FSHB geeni ülemaailmset varieeruvust (Euroopa, Aafrika ja 
Aasia populatsioonid)  
(ii)  tuvastada esivanemlik (šimpans, gorilla, orangutan) FSHB geeni variant; 
(iii)  leida FSHB geeni tuumhaplotüüpide võimalik seos naise viljakusega; 
(iv)  tuvastada polümorfsed variandid FSHB geeniga vahetult piirnevas evolut-
siooniliselt konserveerunud mittekodeerivates piirkondades, mis võiksid 
potentsiaalselt mõjutada FSHB geeni avaldumise taset (in silico analüüs); 
(v)  leida seos FSHB geeni promootoralas paikneva regulatoorse ühenukleo-
tiidse polümorfismi (‒211 aluspaari transkriptsiooni alguskohast, G/T) ja 
seerumi FSH taseme vahel Baltimaade noorte meeste üldvalimis (Eesti, 
Läti, Leedu) ja viljatute Eesti meeste hulgas; 
(vi)  tuvastada assotsiatsioonid FSHB promootoralas paikneva polümorfismi ja 
FSH tasemega seotud reproduktiivsete parameetrite vahel. 
 
Uurimistöö peamised tulemused on: 
1.  FSHB ülemaailmse varieeruvuse mustri uuringu tulemusena, mis hõlmas 222 
indiviidi kuuest Euroopa, Aafrika ja Aasia populatsioonist (Eesti, Mandenka, 
Hiina Han, Korea, Tšehhi, Utah mormoonid ehk Euroopa päritoluga Amee-
rikas elavad indiviidid), ei tuvastatud ühtegi mittesünonüümset FSH valgu 
aminohappe muutust põhjustavat DNA muutust. Kõikides uuritud populat-
sioonides on levinud kõrge sagedusega ühenukleotiidsed polümorfismid, mis 
paiknevad valdavalt geeni mittekodeerivas piirkonnas ning mille alleelide 
vahel on täielik alleelne assotsiatsioon ehk aheldustasakaalutus (Linkage 
Disequilibrium, LD). Geenisisene LD ulatub ka FSHB geeni 3’ ehk alla-
voolu piirkonda, moodustades kuni 6500 aluspaari pikkuseid tihedalt aheldu-
nud alleelide blokke. 
2.  FSHB geen on esindatud kahe tuumhaplotüübiga, haplotüüp 1 ja haplotüüp 
2, mis erinevad üksteisest igas polümorfses positsioonis (yin yang haplo-
tüübid). Euroopa päritoluga populatsioonides on mõlemad haplotüübid 
levinud võrdse sagedusega mitte-Euroopa päritoluga populatsioonides esineb 
valdavalt FSHB geeni haplotüüp 1. Kaks yin yang haplotüüpi ning hulga-
liselt sagedasi polümorfisme viitavad sellele, et antud genoomne piirkond on 
evolutsiooniliselt arenenud tasakaalustava valiku toimel. 
3. Inimese ja inimahvide (šimpans, gorilla, orangutan) FSHB geeni võrdlusel 
ilmnes üksteist ühenukleotiidset erinevust, millest kolm põhjustavad erineva 
aminohappe esinemist valgu järjestuses. Inimahvidele on omane inimese 
FSHB geeni teisele tuumhaplotüübile sarnane haplotüüp. Kõik uuritud 
inimahvid on selle haplotüübi suhtes homosügoodid. 
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4. FSHB geeni tuumhaplotüüpide võimalikku seose leidmiseks naise viljaku-
sega võrreldi haplotüüpide jaotuvust naiste juhuvalimis (n=47, puudub info 
viljakuse kohta) ja kiirelt rasestuvate viljakate (rasestumine toimus kolme 
kuu jooksul pärast rasedusest hoidumise lõpetamist = short time to preg-
nancy – STP) naiste hulgas (n=48) Eestis. Pilootuuringu tulemusena ilmnes, 
et kiirelt rasestuvate viljakate naiste hulgas leidus enam FSHB geeni teise 
tuumhaplotüübi kandjaid. Kuigi FSHB geeni tuumhaplotüüpide puhul on 
kodeeritav valk sarnase aminonappelise järjestusega, võivad tuumhaplo-
tüüpide polümorfismid seonduda tugeva LD tõttu FSHB geenis ja sellega 
piirneval alal regulatoorse alaga, mis mõjutab geeni avaldumist. 
5. FSHB geeni promootori (350 aluspaari enne geeni transkriptsiooni algus-
punkti) in silico analüüsi tulemusena tuvastati potentsiaalne regulatoorne 
polümorfism –211 G/T (rs10835638). Lookus paikneb PRE-elemendis 
(Progesterone Response Element), mis toimib tranksriptsiooniteguri 
kinnituskohana ja reguleerib geeni avaldumist. 
6.  FSHB promootorpiirkonna polümorfismi G/T (positsioonis –211) alleeli-
sageduste võrdlemisel Baltimaade noorte meeste kohordi (Eesti, Läti ja 
Leedu; n=1054) ja Eesti viljatute meeste kohordi (n=1029) vahel ilmnes, et 
minoorne alleel T esineb sagedamini viljatute meeste hulgas. T alleeli 
rikastumine viljatutel meestel võib viidata polümorfismi võimalikule seosele 
mehepoolse viljatuse kujunemises. 
7. Geneetilise assotsiatsiooni analüüsi tulemusena ilmnes oluline seos FSHB 
promootori positsioonis –211 paikneva polümorfismi G ja T alleelide ning 
meeste seerumi FSH taseme vahel. Nii Baltimaade noorte meeste kui ka 
Eesti viljatute meeste hulgas, oli GT- ja TT-genotüüpide kandjatel vastavalt 
16–35% ja 30–50% madalam vereseerumi FSH väärtus võrreldes GG-
genotüüpi omavate indiviididega. 
8.  FSHB promootori positsioonis ‒211 paiknev G/T polümorfism seondub ka 
teiste hormonaalsete ja munandi funktsiooni näitavate parameetritega 
meestel: inhibiin B, testosteroon, seerumi LH tase, spermatosoidide kont-
sentratsioon ja munandite kogumaht. TT-genotüübi kandjatel on ligikaudu 
20% väiksem munandite kogumaht võrreldes GG- ja GT-genotüüpide 
kandjatega. 
 
Polümorfismi seosed mitme meeste reproduktiivtervise parameetriga viitavad 
madala FSH taseme võimalikele pika- ja lühiajalistele efektitele meeste repro-
duktiivpotentsiaalile. Geneetiliselt määratud madalam FSH tase looteeas, 
varajases lapse- ja puberteedieas võib mõjutada erinevaid etappe mehe repro-
duktiivse potentsiaali väljekujunemisel. 
10–20% peredest kogevad mingil ajal oma elus probleeme soovitud laste 
saamisel. Umbes 50% juhtudel on paari viljatuse põhjuseks mehepoolsed 
tegurid. Üheks mehepoolse viljatuse põhjuseks on hormonaalsed häired ja neist 
tulenevad spermatogeneesi häired. On näidatud, et mitmetel juhtudel sõltub 
viljatuse ravi tulemus suures osas mehe FSH tasemest. FSHB geeni promotoor-
piirkonna –211 positsioonis paikneva polümorfismi (rs10835638) minoorse 
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alleeli T kandvatel indiviididel on geneetiliselt määratletud madalam FSH tase 
ning sellest tulenevalt võib nende sooline areng loote- ja lapseeas olla mõjutatud 
pikema aja vältel. Täiskasvanueas võib sellistel meestel viljatuseprobleemide 
korral olla FSH ravi tõhusam ning spetsiifilisem lähtudes indiviidi pärilikust 
eelsoodumusest. FSHB geeni ülemaailmse varieeruvuse muster ning geeni 
promootorpiirkonnas paiknev oluline regulatoorne polümorfism, mis mõjutab 
seerumi FSH taset ja seondub mehepoolse viljatusega, loob tugeva eelduse töö 
jätkamiseks FSHB geeni varieeruvuse seose hindamiseks naise ja terviku paari 
reproduktiivpotentsiaaliga. 
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APPENDIX 
Appendix 1. List of SNPs and variation data identified in FSHB gene are 
deposited in dbSNP database under accession numbers: 
 
211_FSHBprom ss105106771 
m292  ss49785048 
m284  ss49785049 
550312  ss49785050 
611246  ss49785051 
609896  ss49785052 
543  ss49785053 
589  ss49785054 
580646  ss49785055 
595496  ss49785056 
594982  ss49785057 
6169  ss49785058 
1820  ss49785059 
506197  ss49785060 
 
Appendix 2. The full chimpanzee, gorilla and orangutan FSHB gene sequences 
from Ref. II are deposited in NCBI GenBank under accession numbers: 
 
Pan troglodytes DQ302103 
Gorilla gorilla DQ304480 
Pongo pygmaeus DQ304481 
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Appendix 3. Genomic DNA sequence of human FSHB gene (GenBank Acc. 
No. NC_000011.9). Exons are highlighted with grey, translated regions are 
underlined, location of translation start-site (ATG) and translation stop-site 
(TAA) is boxed. 
 
ACAGCTCTTGCCAGGCAAGGCAGCCGACCACAGGTGAGTCTTGGCATCTACCGTTTTCAAGTGGTGACAG 
CTACTTTTGAAATTACAGATTTGTCAGGACATGGAGGACAAAACTAGAGCTTCTCACTACTGTTGTGTAG 
GAAATTTATGCTTGTCAACCTGGCTTGTAAAATATGGTTAATATAACGTAATCACTGTTAGCAAGTAACT 
GACTTTATAGACCAATATGCCTCTCTTCTGAAATGGTCTTATTTTAAACAAATGTGAGCAAAAGAAAATA 
TTTATGAGATTCTAAAAATGAAGACATAATTTTGTAGTATAGAATTTTCTTGGCCAGGAATGGTGGCTCA 
TGCTTGTAATCCCAGCACTTTGGGAGGCCAAGGTCAGAGGATTGCTTGAGCCTGGAAGGTTGAAGATGCA 
GTGATTCATGATTATACCACTGCACTCCAGCCTGGGCAACAGAGCAAGACCCTGTCTCAAGAAAAGAAAA 
GAATTTTATTTTTCTTTTCAGACAAAAATAGACTTTAAAATAATAATGGAAGAACAAATATGATGATCAC 
AATTATCAGAGTAATTACTTTATGACAGTCAGCAATAAGATTCTAATCTTTAAATATTCCTCTGCTTAAA 
TCATTATATTGGAGTTTTGATCTATAATATATTCCCACCCTGACCCAAAAATTGAAGAAGGACAAGGAAA 
AATGTTGTTCCAAGAAACAAAGATGTAAGTAAAAAGGCATAAGGAAGGAAAAAAAACTTTTGAAGCAAAA 
TGTGATTGAGGAGGATGAGCAGACCAATTATTTTTGGTTTGGTCAGCTTACATAATGATTATCGTTCTTT 
GGTTTCTCAGTTTCTAGTGGGCTTCATTGTTTGCTTCCCAGACCAGGATGAAGACACTCCAGTTTTTCTT 
CCTTTTCTGTTGCTGGAAAGCAATCTGCTGCAATAGCTGTGAGCTGACCAACATCACCATTGCAATAGAG 
AAAGAAGAATGTCGTTTCTGCATAAGCATCAACACCACTTGGTGTGCTGGCTACTGCTACACCAGGGTAG 
GTACCATGTTTTGCTGGAAGCAAGGGTGTTGAAGGTCTGTATTAGGCCGGTTTCATTAGTTTCTACTTTA 
TCAATATTTTATGTATTCTAAGTAACAGCCATGAGTCCTTTAGCCAAGACTGTCTGTGTTGTGATTGGGG 
TTAATGACCACGATATCACTTAGATGTTTGGGCTTGGATTTGATTTGGGTAAATTTAGGAAAGCCTCAGA 
TTTAATCTGATCAATTTGGTACTAGTCCAACTTTGCATCTACAGGGAAAAAGTATTTCTATGTTACGTTT 
TTACACATAGAGAGATAAACATGGAAACATACATATATTTAATCATAAAGGACCTATAATATTCTCATAA 
AGGCAATTTCTTTAACTGACACTACATCTTTGACACAAAATCACACCAAAATATGTCTCCAAGTCACATA 
AAAACATAGACAGCCACTTAAAAAAATTGTCTTCCTGGCCCTACTAAATACAAATGCCAAAAAACAGCCT 
GAGAACACAATCAATTCTTGCAGACTGTTAGAACAAAAATGAATCAGCAAACCCACTCCCTTCGTTATAG 
CATTGAGAAAACCAAGACATAGAGGCATCAGTTGCTAGTCTGTGTTTGCAGTTTCCTTGCATTAATACAA 
GTAGAGAAATAGTTTCCATGGTGCTTTCTTTTTTCTCTGCAGCACCCCTAATTATCTATGCAGAATTTCA 
TTCTATAAACTAAAATTGAAAATGGCAACTTTTTAAATGAACGATACTTTATTTGACGGTAAATGAGTTT 
GATCAAACTCCATTTATTACACAATTTATTGCACCTTCTTGGGATATACATTTGGTAGGATGATATTAAA 
ATAAACAGAAGCCCCAATTTCTCTACGCAGTATAAATAATTTTTCCACTGGAAAGTGCTACTACAAATAA 
TTTCTACCTGGATTAAAAATTCTTATATGCAAACTGCATATCCTTTGAAACTAGGAACCCTGCAAAGTAT 
ACAGCTTTCAAGGGAGAAAAATGTCCACAAGGAGTTGGAATATTTAAAATCTTATGTTAGCCTTAGCAAA 
CATGTTAACTTAAGCATTAAAATTTAAAATTATATATTTTTGACCTTTTATAAATACTCAGGGCAGTGTA 
TTTTAAAATATTTTTTCTGAGACATTGGATATCTTTGTTTATGGTTTGTTATTAATACAGCTTTCAATTA 
AATATGAAAAGTCAACTTAAAATCCTGTCATGTTTTTCATCATTTTTCTATGCTAAAATTCAAAGTTCCT 
TTATATTTTGAAAAATAGTTAATATTTTGATATAGCCATAGGAAGTAAGAAAAGAAATTACTTGTATTTT 
CTGGAAGATTTCAAGAACAATTTAGAAATGTAAATAGCATATAGGTCATTTATGAGGTCATGTTTTAATG 
GGTAAATGTTAGAGCAAGCAGTATTCAATTTCTGTCTCATTTTGACTAAGCTAAATAGGAACTTCCACAA 
TACCATAACCTAACTCTCTTCTTAAACTCCTCAGGATCTGGTGTATAAGGACCCAGCCAGGCCCAAAATC 
CAGAAAACATGTACCTTCAAGGAACTGGTATACGAAACAGTGAGAGTGCCCGGCTGTGCTCACCATGCAG 
ATTCCTTGTATACATACCCAGTGGCCACCCAGTGTCACTGTGGCAAGTGTGACAGCGACAGCACTGATTG 
TACTGTGCGAGGCCTGGGGCCCAGCTACTGCTCCTTTGGTGAAATGAAAGAATAAAGATCAGTGGACATT 
TCAGGCCACATACCCTTGTCCTGAAGGACCAAGATATTCAAAAAGTCTGTGTGTGTGCAATGTGCCCAGG 
GGACAAACCACTGGATCAGGGGATTCAGACTCTACTGATCCCTGGTCTACTGGCAGAGGGAACTCTGGGA 
ATTGAGAGTGCTGGGGGCCAGGACTCCATCATGATTCAGCTCTATATTCCTAGGTCTGATTTCATAAGGT 
TTATTCAGTCTTAACTCACAGACTTGTGCCTGGTTTCTTCTTTAAAAATCTTAGAAATCTTCTCAGGCAA 
TGCCTCTCTCTTAGGGGGAAACATAAGCCTAGAAGGAGGAAGCAGTAATGGGAGTGAGTGAAAGAACTAA 
CTGCAGCAGTCTTCTGGTAGACTCTTGGGCCCTCTAGAGCAAGGTCAGCATCTTCAGCATTGTAGCGTCA 
ATGCCTAGCACTCTGCCTGGAACTTAGAAACACAACAATGACTTCTTTAGATCAGAAAGGTCAAGGGTAG 
AAAATACTGGAAGACGATGTTTGAGGTAAGCTGATGAGGCTGCCCGCAGCCACACCAGTCCCATGAAAGT 
TAGTGGCATCAGTTCCACCTCGCCTTTTCTCCAGCACATGGAGTATTGAGACATGATGTATCTTTCTGAA 
TTGTTTGGTACAGATGGGGAGTAACAGAGCTCAAGATTTCCAAGCTATTACTACCAAGCCTGTTAGTTAA 
GGGCAAAGGCAAGAAATTGTAATTTGGGGCTGTGGAAATTAGCCTGCCTCTATTCATTACTTAAACAAAT 
TGATCACATGCTACTAGGCTCCTGCAAAACTCCTTTTTGAGATAAAGGGAAAAAACCAAACTATCTCACC 
CTACCCTCCCTAGGATCCACTTCTTTGGAATGACAAAGGATTTGAAAGTAGGTTTGAAAGCAGTTTCAGC 
AATTTAATAAATATAATTAATTTGTCTACAAATATATTTGTATAAATAAATAGCTCCTTTAGAAAGAATT 
AGCCATGGGGGACGAGGGGAAACTGCTGTTTTCTAGGATCCTGTCTACATCAATCTTCTATTTTATCCAT 
CCATGTTCTCCCAAATCTGTGCTTTCTTTCAACAGGTTATATATTAAAACTATTTCATGAGTTGATTTCT 
85 
TTTAAACGTGTTAACTGTCTTAGTTATGCACTCAGTTTCACACTCATATTGTTTAACTAATTTATTTAAA 
TCTTATTTTTTTAATAAAGATGCTAGCCACCAGAGTCACAGGCTTGGATTGTTTTATGTACAAACAGATG 
ACTTAGATATTCTGTATTTTATAATATTAGTGGAATGAAATCTTAAAATATAATTCCCAGTGTTTCTATA 
AATATTACCTTTCCTTATCTTTGGAGATATTAAAAATAATTTTGTTGGATTTCTGAAGTGTTTTGTCACT 
TAAATTTCCTGTCATTTTTTGAAGACATTTTCTGATGTAATTTGGG 
 
  
 
 
 
 
 
PUBLICATIONS 
CURRICULUM VITAE 
 
Marina Grigorova 
 
Date of Birth:  19.04.1982 
Address:  Department of Biotechnology, 
Institute of Molecular and Cell Biology, 
University of Tartu 
Riia str. 23, 51010, Tartu, Estonia 
E-mail:  marina.grigorova@ut.ee 
 
 
Education 
 
1988–2000 Tartu Slaavi Gymnasium, cum laude 
2000–2004 B.Sc in Biology, Chair of Biotechnology, Institute of Molecular 
and Cell Biology, University of Tartu 
2004–2006 M.Sc in Gene Technology, Chair of Biotechnology, Institute of 
Molecular and Cell Biology, University of Tartu  
2006–2011 Ph.D student in Molecular and Cell biology, Institute of Molecular 
and Cell Biology, University of Tartu   
 
 
Professional employment 
 
2005 technician, Chair of Biotechnology, Institute of Molecular and Cell 
Biology, University of Tartu  
2010 specialist, Estonian Biocentre 
2011– research scientist, Institute of Molecular and Cell Biology, 
University of Tartu  
 
 
Scientific work and activity 
 
In 2002, I started my research in Professor Maris Laan’s group at the Institute of 
Molecular and Cell Biology, University of Tartu, Estonia. One of the focuses of 
the group is genetic basis of male and female fertility, reproductive genetics. 
My study focuses on a complex multigenic process of the establishment and 
regulation of the fertility of the organism. The dominant theme of my research 
relies on the worldwide variation of the follicle-stimulating hormone beta sub-
unit gene (FSHB) and its association with male and female reproductive health. 
 
 
 
173 
Publications 
1. Grigorova M, Rull K, Laan M. Haplotype structure of FSHB, the beta-
subunit gene for fertility-associated follicle-stimulating hormone: possible 
influence of balancing selection. Ann Hum Genet. 2007 71:18–28 
2. Haller K, Salumets A, Grigorova M, Talja I, Salur L, Bene MC, Laan M, 
Uibo R. Putative predictors of antibodies against follicle-stimulating hor-
mone in female infertility: a study based on in vitro fertilization patients. Am 
J Repr Imm. 2007 57:193–200 
3. Grigorova M, Punab M, Ausmees K, Laan M. FSHB promoter poly-
morphism within evolutionary conserved element is associated with serum 
FSH level in men. Hum Reprod. 2008 23:2160–6 
4. Grigorova M, Punab M, Poolamets O, Kelgo P, Ausmees K, Korrovits P, 
Vihljajev V, Laan M. Increased Prevalance of the –211 T allele of follicle 
stimulating hormone (FSH) beta subunit promoter polymorphism and lower 
serum FSH in infertile men. J Clin Endocrinol Metab. 2010 95:100–8. 
5. Nagirnaja L, Rull K, Uusküla L, Hallast P, Grigorova M, Laan M. Geno-
mics and genetics of gonadotropin beta-subunit genes: Unique FSHB and 
duplicated LHB/CGB loci. Mol Cell Endocrinol. 2010 329(1–2):4–16 
6. Grigorova M, Punab M, Zilaitiene B, Erenpreiss J, Ausmees K, Matule-
vicius V, Tsarev I, Jørgensen N, Laan M. Genetically Determined Dosage of 
Follicle-Stimulating Hormone (FSH) Affects Male Reproductive Parameters. 
J Clin Endocrinol Metab. 2011 96:E1534–E1541 
 
 
Fellowships 
2005 Kristjan Jaak’s stipend of Archimedes Academic Fund 
2006 European Testis Workshop travel grant 
2006 Estonian National Contest for Young Scientists at university level, III 
Prize for M.Sc thesis 
2007 Estonian World Council, Inc. Margot M. and Herbert R. Linn stipend 
2009 EcoGene fellowship 2010/2011, for young women in science (women 
returning from maternity leave) 
2009 Tartu University Raefond Scholarship 
2010 International Society of Andrology Young Investigator Travel Award 
(Genetics of Male Infertility symposium 2010) 
2010 Artur Lind Scholarship by Estonian Genome Foundation 
174 
ELULOOKIRJELDUS 
 
Marina Grigorova 
 
Sünniaeg ja koht: 19.aprill1982, Tartu, Eesti 
Aadress: Tartu Ülikool, Molekulaar- ja Rakubioloogia Instituut, 
Biotehnoloogia õppetool, Riia 23, 51010, Tartu 
E-post: marina.grigorova@ut.ee 
 
 
Haridus 
 
1988–2000 Tartu Slaavi gümnaasium, kuldmedal 
2000–2004 B.Sc bioloogia erialal, Biotehnoloogia õppetool, Molekulaar- ja 
rakubioloogia instituut, Tartu Ülikool 
2004–2006  M.Sc geenitehnoloogia erialal, Biotehnoloogia õppetool, 
Molekulaar- ja rakubioloogia instituut, Tartu Ülikool 
2006– Doktoriõpe molekulaar- ja rakubioloogia erialal, Molekulaar- ja 
rakubioloogia instituut, Tartu Ülikool 
 
 
Erialane teenistuskäik 
 
2005 Tartu Ülikool, Molekulaar- ja Rakubioloogia Instituut, 
Biotehnoloogia õppetool, laborant  
2010 Eesti Biokeskus, spetsialist 
2011– Tartu Ülikool, Molekulaar- ja Rakubioloogia Instituut, inimese 
molekulaargeneetika teadur 
 
 
 
Teadustegevus 
Oma teadustöös olen fokuseerinud inimese reproduktiivfunktsiooniga seotud 
Folliikuleid Stimuleeriva Hormooni beeta-alaühikut kodeeriva geeni geneetili-
sele varieeruvusele ja selle seosele inimese reproduktiivtervisega. 
 
 
Publikatsioonid: 
1. Grigorova M, Rull K, Laan M. Haplotype structure of FSHB, the beta-
subunit gene for fertility-associated follicle-stimulating hormone: possible 
influence of balancing selection. Ann Hum Genet. 2007 71:18–28 
2. Haller K, Salumets A, Grigorova M, Talja I, Salur L, Bene MC, Laan M, 
Uibo R. Putative predictors of antibodies against follicle-stimulating 
hormone in female infertility: a study based on in vitro fertilization patients. 
Am J Repr Imm. 2007 57:193–200 
175 
3. Grigorova M, Punab M, Ausmees K, Laan M. FSHB promoter poly-
morphism within evolutionary conserved element is associated with serum 
FSH level in men. Hum Reprod. 2008 23(9):2160–6 
4. Grigorova M, Punab M, Poolamets O, Kelgo P, Ausmees K, Korrovits P, 
Vihljajev V, Laan M. Increased Prevalance of the –211 T allele of follicle 
stimulating hormone (FSH) beta subunit promoter polymorphism and lower 
serum FSH in infertile men. J Clin Endocrinol Metab. 2010 95(1):100–8. 
5. Nagirnaja L, Rull K, Uusküla L, Hallast P, Grigorova M, Laan M. 
Genomics and genetics of gonadotropin beta-subunit genes: Unique FSHB 
and duplicated LHB/CGB loci. Mol Cell Endocrinol. 2010 329(1–2):4–16 
6. Grigorova M, Punab M, Zilaitiene B, Erenpreiss J, Ausmees K, Matu-
levicius V, Tsarev I, Jørgensen N, Laan M. Genetically Determined Dosage 
of Follicle-Stimulating Hormone (FSH) Affects Male Reproductive Para-
meters. J Clin Endocrinol Metab. 2011 96(6):E1534–E1541 
 
 
Stipendiumid: 
2005 Kristjan Jaagu stipendium 
2006 XIV European Testis Workshop travel grant  
2006 Eesti üliõpilaste teadustööde riiklik konkurss,  III preemia magistriõppe 
üliõpilaste astmes 
2007 Ülemaailmse Eesti Kesknõukogu (ÜEKN) Margot M. ja Herbert R. 
Linna stipendium 
2009 Naisteadlase stipendium (EcoGene) 
2010 International Society of Andrology Young Investigator Travel Award 
(Utah/Florence Symposium on Genetics of Male Infertility (USA), 
2010) 
2010 Artur Linnu nimeline stipendium 
 
 
176 
175 
DISSERTATIONES BIOLOGICAE 
UNIVERSITATIS TARTUENSIS 
 
  1. Toivo Maimets. Studies of human oncoprotein p53. Tartu, 1991, 96 p. 
  2. Enn K. Seppet. Thyroid state control over energy metabolism, ion transport 
and contractile functions in rat heart. Tartu, 1991, 135 p.  
  3. Kristjan Zobel. Epifüütsete makrosamblike väärtus õhu saastuse indikaa-
toritena Hamar-Dobani boreaalsetes mägimetsades. Tartu, 1992, 131 lk. 
  4. Andres Mäe. Conjugal mobilization of catabolic plasmids by transposable 
elements in helper plasmids. Tartu, 1992, 91 p. 
  5. Maia Kivisaar. Studies on phenol degradation genes of Pseudomonas sp. 
strain EST 1001. Tartu, 1992, 61 p. 
  6. Allan Nurk. Nucleotide sequences of phenol degradative genes from 
Pseudomonas sp. strain EST 1001 and their transcriptional activation in 
Pseudomonas putida. Tartu, 1992, 72 p. 
  7. Ülo Tamm. The genus Populus L. in Estonia: variation of the species bio-
logy and introduction. Tartu, 1993, 91 p. 
  8. Jaanus Remme. Studies on the peptidyltransferase centre of the E.coli ribo-
some. Tartu, 1993, 68 p. 
  9. Ülo Langel. Galanin and galanin antagonists. Tartu, 1993, 97 p. 
10. Arvo Käärd. The development of an automatic online dynamic fluo-
rescense-based pH-dependent fiber optic penicillin flowthrought biosensor 
for the control of the benzylpenicillin hydrolysis. Tartu, 1993, 117 p. 
11. Lilian Järvekülg. Antigenic analysis and development of sensitive immu-
noassay for potato viruses. Tartu, 1993, 147 p. 
12. Jaak Palumets. Analysis of phytomass partition in Norway spruce. Tartu, 
1993, 47 p. 
13. Arne Sellin. Variation in hydraulic architecture of Picea abies (L.) Karst. 
trees grown under different enviromental conditions. Tartu, 1994, 119 p.  
13. Mati Reeben. Regulation of light neurofilament gene expression. Tartu, 
1994, 108 p. 
14. Urmas Tartes. Respiration rhytms in insects. Tartu, 1995, 109 p. 
15. Ülo Puurand. The complete nucleotide sequence and infections in vitro 
transcripts from cloned cDNA of a potato A potyvirus. Tartu, 1995, 96 p. 
16. Peeter Hõrak. Pathways of selection in avian reproduction: a functional 
framework and its application in the population study of the great tit (Parus 
major). Tartu, 1995, 118 p. 
17. Erkki Truve. Studies on specific and broad spectrum virus resistance in 
transgenic plants. Tartu, 1996, 158 p. 
18. Illar Pata. Cloning and characterization of human and mouse ribosomal 
protein S6-encoding genes. Tartu, 1996, 60 p. 
19. Ülo Niinemets. Importance of structural features of leaves and canopy in 
determining species shade-tolerance in temperature deciduous woody taxa. 
Tartu, 1996, 150 p. 
176 
20. Ants Kurg. Bovine leukemia virus: molecular studies on the packaging 
region and DNA diagnostics in cattle. Tartu, 1996, 104 p. 
21. Ene Ustav. E2 as the modulator of the BPV1 DNA replication. Tartu, 1996, 
100 p. 
22. Aksel Soosaar. Role of helix-loop-helix and nuclear hormone receptor tran-
scription factors in neurogenesis. Tartu, 1996, 109 p. 
23. Maido Remm. Human papillomavirus type 18: replication, transformation 
and gene expression. Tartu, 1997, 117 p. 
24. Tiiu Kull. Population dynamics in Cypripedium calceolus L. Tartu, 1997,  
124 p. 
25. Kalle Olli. Evolutionary life-strategies of autotrophic planktonic micro-
organisms in the Baltic Sea. Tartu, 1997, 180 p. 
26. Meelis Pärtel. Species diversity and community dynamics in calcareous 
grassland communities in Western Estonia. Tartu, 1997, 124 p. 
27. Malle Leht. The Genus Potentilla L. in Estonia, Latvia and Lithuania: dis-
tribution, morphology and taxonomy. Tartu, 1997, 186 p. 
28. Tanel Tenson. Ribosomes, peptides and antibiotic resistance. Tartu, 1997,  
80 p. 
29. Arvo Tuvikene. Assessment of inland water pollution using biomarker 
responses in fish in vivo and in vitro. Tartu, 1997, 160 p. 
30. Urmas Saarma. Tuning ribosomal elongation cycle by mutagenesis of  
23S rRNA. Tartu, 1997, 134 p. 
31. Henn Ojaveer. Composition and dynamics of fish stocks in the gulf of Riga 
ecosystem. Tartu, 1997, 138 p. 
32. Lembi Lõugas. Post-glacial development of vertebrate fauna in Estonian 
water bodies. Tartu, 1997, 138 p. 
33. Margus Pooga. Cell penetrating peptide, transportan, and its predecessors, 
galanin-based chimeric peptides. Tartu, 1998, 110 p. 
34. Andres Saag. Evolutionary relationships in some cetrarioid genera (Liche-
nized Ascomycota). Tartu, 1998, 196 p. 
35. Aivar Liiv. Ribosomal large subunit assembly in vivo. Tartu, 1998, 158 p. 
36. Tatjana Oja. Isoenzyme diversity and phylogenetic affinities among the 
eurasian annual bromes (Bromus L., Poaceae). Tartu, 1998, 92 p. 
37. Mari Moora. The influence of arbuscular mycorrhizal (AM) symbiosis on 
the competition and coexistence of calcareous crassland plant species. 
Tartu, 1998, 78 p. 
38. Olavi Kurina. Fungus gnats in Estonia (Diptera: Bolitophilidae, Kero-
platidae, Macroceridae, Ditomyiidae, Diadocidiidae, Mycetophilidae). 
Tartu, 1998, 200 p.  
39. Andrus Tasa. Biological leaching of shales: black shale and oil shale. 
Tartu, 1998, 98 p. 
40. Arnold Kristjuhan. Studies on transcriptional activator properties of tumor 
suppressor protein p53. Tartu, 1998, 86 p. 
41. Sulev Ingerpuu. Characterization of some human myeloid cell surface and 
nuclear differentiation antigens. Tartu, 1998, 163 p. 
177 
42. Veljo Kisand. Responses of planktonic bacteria to the abiotic and biotic 
factors in the shallow lake Võrtsjärv. Tartu, 1998, 118 p. 
43. Kadri Põldmaa. Studies in the systematics of hypomyces and allied genera 
(Hypocreales, Ascomycota). Tartu, 1998, 178 p. 
44. Markus Vetemaa. Reproduction parameters of fish as indicators in 
environmental monitoring. Tartu, 1998, 117 p. 
45. Heli Talvik. Prepatent periods and species composition of different 
Oesophagostomum spp. populations in Estonia and Denmark. Tartu, 1998, 
104 p. 
46. Katrin Heinsoo. Cuticular and stomatal antechamber conductance to water 
vapour diffusion in Picea abies (L.) karst. Tartu, 1999, 133 p. 
47. Tarmo Annilo. Studies on mammalian ribosomal protein S7. Tartu, 1998, 
77 p. 
48. Indrek Ots. Health state indicies of reproducing great tits (Parus major): 
sources of variation and connections with life-history traits. Tartu, 1999, 
117 p. 
49. Juan Jose Cantero. Plant community diversity and habitat relationships in 
central Argentina grasslands. Tartu, 1999, 161 p. 
50. Rein Kalamees. Seed bank, seed rain and community regeneration in 
Estonian calcareous grasslands. Tartu, 1999, 107 p. 
51. Sulev Kõks. Cholecystokinin (CCK) — induced anxiety in rats: influence 
of environmental stimuli and involvement of endopioid mechanisms and 
erotonin. Tartu, 1999, 123 p. 
52. Ebe Sild. Impact of increasing concentrations of O3 and CO2 on wheat, 
clover and pasture. Tartu, 1999, 123 p. 
53. Ljudmilla Timofejeva. Electron microscopical analysis of the synaptone-
mal complex formation in cereals. Tartu, 1999, 99 p. 
54. Andres Valkna. Interactions of galanin receptor with ligands and  
G-proteins: studies with synthetic peptides. Tartu, 1999, 103 p. 
55. Taavi Virro. Life cycles of planktonic rotifers in lake Peipsi. Tartu, 1999, 
101 p. 
56. Ana Rebane. Mammalian ribosomal protein S3a genes and intron-encoded 
small nucleolar RNAs U73 and U82. Tartu, 1999, 85 p. 
57. Tiina Tamm. Cocksfoot mottle virus: the genome organisation and transla-
tional strategies. Tartu, 2000,  101 p. 
58. Reet Kurg. Structure-function relationship of the bovine papilloma virus E2 
protein. Tartu, 2000, 89 p. 
59. Toomas Kivisild. The origins of Southern and Western Eurasian popula-
tions: an mtDNA study. Tartu, 2000, 121 p. 
60. Niilo Kaldalu. Studies of the TOL plasmid transcription factor XylS. Tartu 
2000. 88 p. 
61. Dina Lepik. Modulation of viral DNA replication by tumor suppressor 
protein p53. Tartu 2000. 106 p. 
62. Kai Vellak. Influence of different factors on the diversity of the bryophyte 
vegetation in forest and wooded meadow communities. Tartu 2000. 122 p. 
178 
63. Jonne Kotta. Impact of eutrophication and biological invasionas on the 
structure and functions of benthic macrofauna. Tartu 2000. 160 p. 
64. Georg Martin. Phytobenthic communities of the Gulf of Riga and the inner 
sea the West-Estonian archipelago. Tartu, 2000. 139 p. 
65.  Silvia Sepp. Morphological and genetical variation of Alchemilla L. in 
Estonia. Tartu, 2000. 124 p. 
66. Jaan Liira. On the determinants of structure and diversity in herbaceous 
plant communities. Tartu, 2000. 96 p. 
67. Priit Zingel. The role of planktonic ciliates in lake ecosystems. Tartu 2001. 
111 p. 
68. Tiit Teder. Direct and indirect effects in Host-parasitoid interactions: 
ecological and evolutionary consequences. Tartu 2001. 122 p. 
69. Hannes Kollist. Leaf apoplastic ascorbate as ozone scavenger and its 
transport across the plasma membrane. Tartu 2001. 80 p. 
70. Reet Marits. Role of two-component regulator system PehR-PehS and 
extracellular protease PrtW in virulence of Erwinia Carotovora subsp. 
Carotovora. Tartu 2001. 112 p. 
71. Vallo Tilgar. Effect of calcium supplementation on reproductive perfor-
mance of the pied flycatcher Ficedula hypoleuca and the great tit Parus 
major, breeding in Nothern temperate forests. Tartu, 2002. 126 p. 
72. Rita Hõrak. Regulation of transposition of transposon Tn4652 in 
Pseudomonas putida. Tartu, 2002. 108 p. 
73. Liina Eek-Piirsoo. The effect of fertilization, mowing and additional 
illumination on the structure of a species-rich grassland community. Tartu, 
2002. 74 p. 
74. Krõõt Aasamaa. Shoot hydraulic conductance and stomatal conductance of 
six temperate deciduous tree species. Tartu, 2002. 110 p. 
75. Nele Ingerpuu. Bryophyte diversity and vascular plants. Tartu, 2002. 
112 p. 
76. Neeme Tõnisson. Mutation detection by primer extension on oligo-
nucleotide microarrays. Tartu, 2002. 124 p. 
77. Margus Pensa. Variation in needle retention of Scots pine in relation to 
leaf morphology, nitrogen conservation and tree age. Tartu, 2003. 110 p. 
78. Asko Lõhmus. Habitat preferences and quality for birds of prey: from 
principles to applications. Tartu, 2003. 168 p. 
79. Viljar Jaks. p53 — a switch in cellular circuit. Tartu, 2003. 160 p. 
80. Jaana Männik. Characterization and genetic studies of four ATP-binding 
cassette (ABC) transporters. Tartu, 2003. 140 p. 
81. Marek Sammul. Competition and coexistence of clonal plants in relation to 
productivity. Tartu, 2003. 159 p 
82. Ivar Ilves. Virus-cell interactions in the replication cycle of bovine 
papillomavirus type 1. Tartu, 2003. 89 p.  
83. Andres Männik. Design and characterization of a novel vector system 
based on the stable replicator of bovine papillomavirus type 1. Tartu, 2003. 
109 p. 
179 
84. Ivika Ostonen. Fine root structure, dynamics and proportion in net 
primary production of Norway spruce forest ecosystem in relation to site 
conditions. Tartu, 2003. 158 p. 
85. Gudrun Veldre. Somatic status of 12–15-year-old Tartu schoolchildren. 
Tartu, 2003. 199 p. 
86.  Ülo Väli. The greater spotted eagle Aquila clanga and the lesser spotted 
eagle A. pomarina: taxonomy, phylogeography and ecology. Tartu, 2004. 
159 p.  
87. Aare Abroi. The determinants for the native activities of the bovine 
papillomavirus type 1 E2 protein are separable. Tartu, 2004. 135 p. 
88. Tiina Kahre. Cystic fibrosis in Estonia. Tartu, 2004. 116 p. 
89. Helen Orav-Kotta. Habitat choice and feeding activity of benthic suspension 
feeders and mesograzers in the northern Baltic Sea. Tartu, 2004. 117 p. 
90. Maarja Öpik. Diversity of arbuscular mycorrhizal fungi in the roots of 
perennial plants and their effect on plant performance. Tartu, 2004. 175 p.  
91. Kadri Tali. Species structure of Neotinea ustulata. Tartu, 2004. 109 p. 
92. Kristiina Tambets. Towards the understanding of post-glacial spread of 
human mitochondrial DNA haplogroups in Europe and beyond: a phylo-
geographic approach. Tartu, 2004. 163 p. 
93. Arvi Jõers. Regulation of p53-dependent transcription. Tartu, 2004. 103 p. 
94. Lilian Kadaja. Studies on modulation of the activity of tumor suppressor 
protein p53. Tartu, 2004. 103 p. 
95. Jaak Truu. Oil shale industry wastewater: impact on river microbial  
community and possibilities for bioremediation. Tartu, 2004. 128 p. 
96. Maire Peters. Natural horizontal transfer of the pheBA operon. Tartu, 
2004. 105 p. 
97. Ülo Maiväli. Studies on the structure-function relationship of the bacterial 
ribosome. Tartu, 2004. 130 p.  
98. Merit Otsus. Plant community regeneration and species diversity in dry 
calcareous grasslands. Tartu, 2004. 103 p. 
99. Mikk Heidemaa. Systematic  studies  on  sawflies of  the  genera Dolerus,  
Empria,  and  Caliroa (Hymenoptera:  Tenthredinidae). Tartu, 2004. 167 p. 
100. Ilmar Tõnno. The impact of nitrogen and phosphorus concentration and 
N/P ratio on cyanobacterial dominance and N2 fixation in some Estonian 
lakes. Tartu, 2004. 111 p. 
101. Lauri Saks. Immune function, parasites, and carotenoid-based ornaments 
in greenfinches. Tartu, 2004. 144 p.  
102. Siiri Rootsi. Human Y-chromosomal variation in European populations. 
Tartu, 2004. 142 p. 
103. Eve Vedler. Structure of the 2,4-dichloro-phenoxyacetic acid-degradative 
plasmid pEST4011. Tartu, 2005. 106 p.  
104.  Andres Tover. Regulation of transcription of the phenol degradation 
pheBA operon in Pseudomonas putida. Tartu, 2005. 126 p. 
105.  Helen Udras. Hexose  kinases  and  glucose transport  in  the  yeast Han-
senula  polymorpha. Tartu, 2005. 100 p. 
180 
106. Ave Suija. Lichens and lichenicolous fungi in Estonia: diversity, distri-
bution patterns, taxonomy. Tartu, 2005. 162 p. 
107. Piret Lõhmus. Forest lichens and their substrata in Estonia. Tartu, 2005. 
162 p.  
108. Inga Lips. Abiotic factors controlling the cyanobacterial bloom occur-
rence in the Gulf of Finland. Tartu, 2005. 156 p. 
109.  Kaasik, Krista. Circadian clock genes in mammalian clockwork, meta-
bolism and behaviour. Tartu, 2005. 121 p. 
110.  Juhan Javoiš. The effects of experience on host acceptance in ovipositing 
moths. Tartu, 2005. 112 p.  
111.  Tiina Sedman. Characterization  of  the  yeast Saccharomyces  cerevisiae 
mitochondrial  DNA  helicase  Hmi1. Tartu, 2005. 103 p.  
112.  Ruth Aguraiuja. Hawaiian endemic fern lineage Diellia (Aspleniaceae): 
distribution, population structure and ecology. Tartu, 2005. 112 p.  
113.  Riho Teras. Regulation of transcription from the fusion promoters ge-
nerated by transposition of Tn4652 into the upstream region of pheBA 
operon in Pseudomonas putida. Tartu, 2005. 106 p.  
114.  Mait Metspalu. Through the course of prehistory in india: tracing the 
mtDNA trail. Tartu, 2005. 138 p.  
115. Elin Lõhmussaar. The comparative patterns of linkage disequilibrium in 
European populations and its implication for genetic association studies. 
Tartu, 2006. 124 p. 
116. Priit Kupper. Hydraulic and environmental limitations to leaf water rela-
tions in trees with respect to canopy position. Tartu, 2006. 126 p. 
117. Heili Ilves. Stress-induced transposition of Tn4652 in Pseudomonas 
Putida. Tartu, 2006. 120 p. 
118. Silja Kuusk. Biochemical properties of Hmi1p, a DNA helicase from 
Saccharomyces cerevisiae mitochondria. Tartu, 2006. 126 p. 
119. Kersti Püssa. Forest edges on medium resolution landsat thematic mapper 
satellite images. Tartu, 2006. 90 p. 
120. Lea Tummeleht. Physiological condition and immune function in great 
tits (Parus major l.): Sources of variation and trade-offs in relation to 
growth. Tartu, 2006. 94 p. 
121. Toomas Esperk. Larval instar as a key element of insect growth schedules. 
Tartu, 2006. 186 p.  
122. Harri Valdmann. Lynx (Lynx lynx) and wolf (Canis lupus)  in the Baltic 
region:  Diets,  helminth parasites and genetic variation. Tartu, 2006. 102 p. 
123. Priit Jõers. Studies of the mitochondrial helicase Hmi1p in Candida 
albicans and Saccharomyces cerevisia. Tartu, 2006. 113 p. 
124. Kersti Lilleväli. Gata3 and Gata2 in inner ear development. Tartu, 2007. 
123 p.  
125. Kai Rünk. Comparative ecology of three fern species: Dryopteris carthu-
siana (Vill.) H.P. Fuchs, D. expansa (C. Presl) Fraser-Jenkins & Jermy and 
D. dilatata (Hoffm.) A. Gray (Dryopteridaceae). Tartu, 2007. 143 p.  
181 
126. Aveliina Helm. Formation and persistence of dry grassland diversity: role 
of human history and landscape structure. Tartu, 2007. 89 p.  
127. Leho Tedersoo. Ectomycorrhizal fungi: diversity and community structure 
in Estonia, Seychelles and Australia. Tartu, 2007. 233 p.  
128. Marko Mägi. The habitat-related variation of reproductive performance of 
great tits in a deciduous-coniferous forest mosaic: looking for causes and 
consequences. Tartu, 2007. 135 p.  
129. Valeria Lulla. Replication strategies and applications of Semliki Forest 
virus. Tartu, 2007. 109 p.  
130. Ülle Reier. Estonian threatened vascular plant species: causes of rarity and 
conservation. Tartu, 2007. 79 p. 
131. Inga Jüriado. Diversity of lichen species in Estonia: influence of regional 
and local factors. Tartu, 2007. 171 p. 
132. Tatjana Krama. Mobbing behaviour in birds: costs and reciprocity based 
cooperation. Tartu, 2007. 112 p. 
133. Signe Saumaa. The role of DNA mismatch repair and oxidative DNA 
damage defense systems in avoidance of stationary phase mutations in 
Pseudomonas putida. Tartu, 2007. 172 p. 
134. Reedik Mägi. The linkage disequilibrium and the selection of genetic 
markers for association studies in european populations. Tartu, 2007. 96 p.  
135. Priit Kilgas. Blood parameters as indicators of physiological condition and 
skeletal development in great tits (Parus major): natural variation and 
application in the reproductive ecology of birds. Tartu, 2007. 129 p.  
136. Anu Albert. The role of water salinity in structuring eastern Baltic coastal 
fish communities. Tartu, 2007. 95 p.  
137. Kärt Padari. Protein transduction mechanisms of transportans. Tartu, 2008. 
128 p. 
138. Siiri-Lii Sandre. Selective forces on larval colouration in a moth. Tartu, 
2008. 125 p. 
139. Ülle Jõgar. Conservation and restoration of semi-natural floodplain mea-
dows and their rare plant species. Tartu, 2008. 99 p. 
140. Lauri Laanisto. Macroecological approach in vegetation science: gene-
rality of ecological relationships at the global scale. Tartu, 2008. 133 p. 
141. Reidar Andreson. Methods and software for predicting PCR failure rate in 
large genomes. Tartu, 2008. 105 p.  
142. Birgot Paavel. Bio-optical properties of turbid lakes. Tartu, 2008. 175 p. 
143. Kaire Torn. Distribution and ecology of charophytes in the Baltic Sea. 
Tartu, 2008, 98 p.  
144. Vladimir Vimberg. Peptide mediated macrolide resistance. Tartu, 2008, 
190 p. 
145. Daima Örd. Studies on the stress-inducible pseudokinase TRB3, a novel 
inhibitor of transcription factor ATF4. Tartu, 2008, 108 p. 
146. Lauri Saag. Taxonomic and ecologic problems in the genus Lepraria 
(Stereocaulaceae, lichenised Ascomycota). Tartu, 2008, 175 p. 
182 
147. Ulvi Karu. Antioxidant protection, carotenoids and coccidians in green-
finches – assessment of the costs of immune activation and mechanisms of 
parasite resistance in a passerine with carotenoid-based ornaments. Tartu, 
2008, 124 p. 
148. Jaanus Remm. Tree-cavities in forests: density, characteristics and occu-
pancy by animals. Tartu, 2008, 128 p. 
149. Epp Moks. Tapeworm parasites Echinococcus multilocularis and E. gra-
nulosus in Estonia: phylogenetic relationships and occurrence in wild 
carnivores and ungulates. Tartu, 2008, 82 p. 
150. Eve Eensalu. Acclimation of stomatal structure and function in tree ca-
nopy: effect of light and CO2 concentration. Tartu, 2008, 108 p. 
151. Janne Pullat. Design, functionlization and application of an in situ 
synthesized oligonucleotide microarray. Tartu, 2008, 108 p. 
152. Marta Putrinš. Responses of Pseudomonas putida to phenol-induced 
metabolic and stress signals. Tartu, 2008, 142 p.  
153.  Marina Semtšenko. Plant root behaviour: responses to neighbours and 
physical obstructions. Tartu, 2008, 106 p. 
154. Marge Starast. Influence of cultivation techniques on productivity and 
fruit quality of some Vaccinium and Rubus taxa. Tartu, 2008, 154 p.  
155. Age Tats. Sequence motifs influencing the efficiency of translation. Tartu, 
2009, 104 p. 
156. Radi Tegova. The role of specialized DNA polymerases in mutagenesis in 
Pseudomonas putida. Tartu, 2009, 124 p. 
157. Tsipe Aavik. Plant species richness, composition and functional trait 
pattern in agricultural landscapes – the role of land use intensity and land-
scape structure. Tartu, 2008, 112 p. 
158. Kaja Kiiver. Semliki forest virus based vectors and cell lines for studying 
the replication and interactions of alphaviruses and hepaciviruses. Tartu, 
2009, 104 p. 
159. Meelis Kadaja. Papillomavirus Replication Machinery Induces Genomic 
Instability in its Host Cell. Tartu, 2009, 126 p. 
160. Pille Hallast. Human and chimpanzee Luteinizing hormone/Chorionic 
Gonadotropin beta (LHB/CGB) gene clusters: diversity and divergence of 
young duplicated genes. Tartu, 2009, 168 p. 
161. Ain Vellak. Spatial and temporal aspects of plant species conservation. 
Tartu, 2009, 86 p. 
162. Triinu Remmel. Body size evolution in insects with different colouration 
strategies: the role of predation risk. Tartu, 2009, 168 p. 
163. Jaana Salujõe. Zooplankton as the indicator of ecological quality and fish 
predation in lake ecosystems. Tartu, 2009, 129 p. 
164. Ele Vahtmäe. Mapping benthic habitat with remote sensing in optically 
complex coastal environments. Tartu, 2009, 109 p.  
165. Liisa Metsamaa. Model-based assessment to improve the use of remote 
sensing in recognition and quantitative mapping of cyanobacteria. Tartu, 
2009, 114 p. 
183 
166. Pille Säälik. The role of endocytosis in the protein transduction by cell-
penetrating peptides. Tartu, 2009, 155 p. 
167. Lauri Peil. Ribosome assembly factors in Escherichia coli. Tartu, 2009,  
147 p. 
168. Lea Hallik. Generality and specificity in light harvesting, carbon gain 
capacity and shade tolerance among plant functional groups. Tartu, 2009, 
99 p. 
169. Mariliis Tark. Mutagenic potential of DNA damage repair and tolerance 
mechanisms under starvation stress. Tartu, 2009, 191 p. 
170. Riinu Rannap. Impacts of habitat loss and restoration on amphibian po-
pulations. Tartu, 2009, 117 p. 
171. Maarja Adojaan. Molecular variation of HIV-1 and the use of this know-
ledge in vaccine development. Tartu, 2009, 95 p. 
172. Signe Altmäe. Genomics and transcriptomics of human induced ovarian 
folliculogenesis. Tartu, 2010, 179 p. 
173. Triin Suvi. Mycorrhizal fungi of native and introduced trees in the 
Seychelles Islands. Tartu, 2010, 107 p. 
174. Velda Lauringson. Role of suspension feeding in a brackish-water coastal 
sea. Tartu, 2010, 123 p. 
175. Eero Talts. Photosynthetic cyclic electron transport – measurement and 
variably proton-coupled mechanism. Tartu, 2010, 121 p.  
176. Mari Nelis. Genetic structure of the Estonian population and genetic 
distance from other populations of European descent. Tartu, 2010, 97 p. 
177. Kaarel Krjutškov. Arrayed Primer Extension-2 as a multiplex PCR-based 
method for nucleic acid variation analysis: method and applications. Tartu, 
2010, 129 p. 
178. Egle Köster. Morphological and genetical variation within species complexes: 
Anthyllis vulneraria s. l. and Alchemilla vulgaris (coll.). Tartu, 2010, 101 p. 
179. Erki Õunap. Systematic studies on the subfamily Sterrhinae (Lepidoptera: 
Geometridae). Tartu, 2010, 111 p.  
180. Merike Jõesaar. Diversity of key catabolic genes at degradation of phenol 
and p-cresol in pseudomonads. Tartu, 2010, 125 p. 
181. Kristjan Herkül. Effects of physical disturbance and habitat-modifying 
species on sediment properties and benthic communities in the northern 
Baltic Sea. Tartu, 2010, 123 p. 
182. Arto Pulk. Studies on bacterial ribosomes by chemical modification 
approaches. Tartu, 2010, 161 p. 
183. Maria Põllupüü. Ecological relations of cladocerans in a brackish-water 
ecosystem. Tartu, 2010, 126 p.  
184. Toomas Silla. Study of the segregation mechanism of the Bovine 
Papillomavirus Type 1. Tartu, 2010, 188 p. 
185. Gyaneshwer Chaubey. The demographic history of India: A perspective 
based on genetic evidence. Tartu, 2010, 184 p. 
186. Katrin Kepp. Genes involved in cardiovascular traits: detection of genetic 
variation in Estonian and Czech populations. Tartu, 2010, 164 p. 
184 
187. Virve Sõber. The role of biotic interactions in plant reproductive 
performance. Tartu, 2010, 92 p. 
188. Kersti Kangro. The response of phytoplankton community to the changes 
in nutrient loading. Tartu, 2010, 144 p. 
189. Joachim M. Gerhold. Replication and Recombination of mitochondrial 
DNA in Yeast. Tartu, 2010, 120 p. 
190. Helen Tammert. Ecological role of physiological and phylogenetic 
diversity in aquatic bacterial communities. Tartu, 2010, 140 p. 
191. Elle Rajandu. Factors determining plant and lichen species diversity and 
composition in Estonian Calamagrostis and Hepatica site type forests. 
Tartu, 2010, 123 p. 
192. Paula Ann Kivistik. ColR-ColS signalling system and transposition of 
Tn4652 in the adaptation of Pseudomonas putida. Tartu, 2010, 118 p. 
193. Siim Sõber. Blood pressure genetics: from candidate genes to genome-
wide association studies. Tartu, 2011, 120 p. 
194. Kalle Kipper. Studies on the role of helix 69 of 23S rRNA in the factor-
dependent stages of translation initiation, elongation, and termination. 
Tartu, 2011, 178 p. 
195. Triinu Siibak. Effect of antibiotics on ribosome assembly is indirect. 
Tartu, 2011, 134 p. 
196. Tambet Tõnissoo. Identification and molecular analysis of the role of 
guanine nucleotide exchange factor RIC-8 in mouse development and 
neural function. Tartu, 2011, 110 p. 
197. Helin Räägel. Multiple faces of cell-penetrating peptides – their intra-
cellular trafficking, stability and endosomal escape during protein trans-
duction. Tartu, 2011, 161 p.  
198. Andres Jaanus. Phytoplankton in Estonian coastal waters – variability, 
trends and response to environmental pressures. Tartu, 2011, 157 p. 
199. Tiit Nikopensius. Genetic predisposition to nonsyndromic orofacial clefts. 
Tartu, 2011, 152 p. 
200. Signe Värv. Studies on the mechanisms of RNA polymerase II-dependent 
transcription elongation. Tartu, 2011, 108 p. 
201. Kristjan Välk. Gene expression profiling and genome-wide association 
studies of non-small cell lung cancer. Tartu, 2011, 98 p. 
202. Arno Põllumäe. Spatio-temporal patterns of native and invasive zoo-
plankton species under changing climate and eutrophication conditions. 
Tartu, 2011, 153 p. 
203. Egle Tammeleht. Brown bear (Ursus arctos) population structure, demo-
graphic processes and variations in diet in northern Eurasia. Tartu, 2011, 
143 p.  
205. Teele Jairus. Species composition and host preference among ectomy-
corrhizal fungi in Australian and African ecosystems. Tartu, 2011, 106 p.   
206. Kessy Abarenkov. PlutoF – cloud database and computing services 
supporting biological research. Tartu, 2011, 125 p.  
